1
|
Baker S, Biroli P, van Kippersluis H, von Hinke S. Advantageous early-life environments cushion the genetic risk for ischemic heart disease. Proc Natl Acad Sci U S A 2024; 121:e2314056121. [PMID: 38917008 DOI: 10.1073/pnas.2314056121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2023] [Accepted: 04/18/2024] [Indexed: 06/27/2024] Open
Abstract
In one of the first papers on the impact of early-life conditions on individuals' health in older age, Barker and Osmond [Lancet, 327, 1077-1081 (1986)] show a strong positive relationship between infant mortality rates in the 1920s and ischemic heart disease in the 1970s. We merge historical data on infant mortality rates to 370,000 individual records in the UK Biobank using information on local area and year of birth. We replicate the association between the early-life infant mortality rate and later-life ischemic heart disease in our sample. We then go "beyond Barker," by showing considerable genetic heterogeneity in this association that is robust to within-area as well as within-family analyses. We find no association between the polygenic index and heart disease in areas with the lowest infant mortality rates, but a strong positive relationship in areas characterized by high infant mortality. These findings suggest that advantageous environments can cushion one's genetic disease risk.
Collapse
Affiliation(s)
- Samuel Baker
- School of Economics, University of Bristol, Bristol BS8 1TU, United Kingdom
| | - Pietro Biroli
- Department of Economic Sciences, University of Bologna, Bologna, Italy
| | - Hans van Kippersluis
- Erasmus School of Economics, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands
| | - Stephanie von Hinke
- School of Economics, University of Bristol, Bristol BS8 1TU, United Kingdom
- Institute for Fiscal Studies, London WC1E 7AE, United Kingdom
| |
Collapse
|
2
|
Teng EYH, Liao KCW, Chang YC. Commentary to the article "Metabolic syndrome and the risk of preclinical heart failure: Insights after 17 years of follow-up from the STANISLAS Cohort". Cardiology 2022; 147:288-289. [PMID: 35231910 DOI: 10.1159/000523819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Accepted: 02/17/2022] [Indexed: 11/19/2022]
Abstract
Not required for a commentary.
Collapse
Affiliation(s)
- Ethan Yen-Hua Teng
- Biological Programs for Younger Scholar, Academia Sinica, Taipei, Taiwan
| | | | - Yi-Cheng Chang
- Department of Internal Medicine, National Taiwan University, Taipei, Taiwan
- Graduate Institute of Medical Genetics and Proteomics, National Taiwan University, Taipei, Taiwan
- Institutes of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
| |
Collapse
|
3
|
Xie T, Gorenjak V, Stathopoulou MG, Dadé S, Marouli E, Masson C, Murray H, Lamont J, Fitzgerald P, Deloukas P, Visvikis-Siest S. Epigenome-wide association study detects a novel loci associated with central obesity in healthy subjects. BMC Med Genomics 2021; 14:233. [PMID: 34556110 PMCID: PMC8459469 DOI: 10.1186/s12920-021-01077-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Accepted: 09/06/2021] [Indexed: 12/05/2022] Open
Abstract
Background and aims Central obesity is a condition that poses a significant risk to global health and requires the employment of novel scientific methods for exploration. The objective of this study is to use DNA methylation analysis to detect DNA methylation loci linked to obesity phenotypes, i.e. waist circumference and waist-to-hip ratio adjusted for BMI. Methods and results Two-hundred and ten healthy European participants from the STANISLAS Family Study (SFS), comprising 73 nuclear families, were comprehensively assessed for methylation status using Illumina Infinium HumanMethylation450 BeadChip. An epigenome-wide association study was performed, which identified a CpG site cg16170243 located on chromosome 18q21.2 significantly associated with waist circumference, after adjusting for BMI (β = 2.32, SE = 0.41, Padj = 0.048). Cg16170243 corresponds to a 50 bp-length human methylation oligoprobe located within the AC090241.2 gene that overlaps ST8SIA5 gene. No significant association was observed with waist-to-hip ratio adjusted for BMI (Padj > 0.05). Conclusions A novel association between DNA methylation and WC was identified, which is demonstrating that epigenetic mechanisms may have a significant impact on waist circumference ratio in healthy individuals. Further studies are warranted to address the causal effects of this association. Supplementary Information The online version contains supplementary material available at 10.1186/s12920-021-01077-9.
Collapse
Affiliation(s)
- Ting Xie
- INSERM UMR U1122, IGE-PCV, Faculté de Pharmacie, Université de Lorraine, 30 Rue Lionnois, 54000, Nancy, France.,CRCT, INSERM U1037, 31037, Toulouse, France.,Université Paul Sabatier III', 31400, Toulouse, France
| | - Vesna Gorenjak
- INSERM UMR U1122, IGE-PCV, Faculté de Pharmacie, Université de Lorraine, 30 Rue Lionnois, 54000, Nancy, France
| | - Maria G Stathopoulou
- INSERM UMR U1122, IGE-PCV, Faculté de Pharmacie, Université de Lorraine, 30 Rue Lionnois, 54000, Nancy, France.,'Université Côte d'Azur', INSERM U1065, C3M, 06204, Nice, France
| | - Sébastien Dadé
- INSERM UMR U1122, IGE-PCV, Faculté de Pharmacie, Université de Lorraine, 30 Rue Lionnois, 54000, Nancy, France
| | | | - Christine Masson
- INSERM UMR U1122, IGE-PCV, Faculté de Pharmacie, Université de Lorraine, 30 Rue Lionnois, 54000, Nancy, France
| | | | | | | | | | - Sophie Visvikis-Siest
- INSERM UMR U1122, IGE-PCV, Faculté de Pharmacie, Université de Lorraine, 30 Rue Lionnois, 54000, Nancy, France.
| |
Collapse
|
4
|
Kafyra M, Kalafati IP, Kumar S, Kontoe MS, Masson C, Siest S, Dedoussis GV. Dietary Patterns, Blood Pressure and the Glycemic and Lipidemic Profile of Two Teenage, European Populations. Nutrients 2021; 13:198. [PMID: 33435217 PMCID: PMC7826952 DOI: 10.3390/nu13010198] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Revised: 12/28/2020] [Accepted: 01/07/2021] [Indexed: 12/11/2022] Open
Abstract
The present study sought to retrospectively investigate the dietary habits of two adolescent, European populations from the cross-sectional Greek TEENAGE Study and French STANISLAS Family Study. We aimed to explore the relation between the populations' dietary patterns and blood pressure, glycemic and lipidemic profile. Dietary patterns were extracted via Principal Component Analysis (PCA), based on data collected from two 24 h dietary recalls for the TEENAGE study and a 3-day food consumption diary for the STANISLAS study. Multiple linear regressions and mixed models analyses, adjusting for confounding factors, were employed to investigate potential associations. A total of 766 Greek teenagers and 287 French teenagers, were included in analyses. Five dietary patterns were extracted for each population accounting for 49.35% and 46.69% of their respective total variance, with similarities regarding the consumption of specific food groups (i.e., western-type foods). In the TEENAGE Study, the "chicken and sugars" pattern was associated with lower CRP levels, after adjusting for confounding factors (p-value < 0.01). The "high protein and animal fat" dietary pattern of the STANISLAS Family Study was related to higher BMI (p-value < 0.01) and higher triglycerides levels (p-value < 0.01). Our findings summarize the dietary habits of two teenage, European populations and their associations with cardiometabolic risk factors.
Collapse
Affiliation(s)
- Maria Kafyra
- Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece or (M.K.); (I.P.K.)
- IGE-PCV, Université de Lorraine, F-54000 Nancy, France; (S.K.); (M.S.K.); (C.M.); (S.S.)
| | - Ioanna Panagiota Kalafati
- Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece or (M.K.); (I.P.K.)
| | - Satish Kumar
- IGE-PCV, Université de Lorraine, F-54000 Nancy, France; (S.K.); (M.S.K.); (C.M.); (S.S.)
| | | | - Christine Masson
- IGE-PCV, Université de Lorraine, F-54000 Nancy, France; (S.K.); (M.S.K.); (C.M.); (S.S.)
| | - Sophie Siest
- IGE-PCV, Université de Lorraine, F-54000 Nancy, France; (S.K.); (M.S.K.); (C.M.); (S.S.)
| | - George V. Dedoussis
- Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece or (M.K.); (I.P.K.)
- IGE-PCV, Université de Lorraine, F-54000 Nancy, France; (S.K.); (M.S.K.); (C.M.); (S.S.)
| |
Collapse
|
5
|
El Shamieh S, Stathopoulou MG, Bonnefond A, Ndiaye NC, Lecoeur C, Meyre D, Dadé S, Chedid P, Salami A, Shahabi P, Dedoussis GV, Froguel P, Visvikis-Siest S. Obesity status modifies the association between rs7556897T>C in the intergenic region SLC19A3-CCL20 and blood pressure in French children. Clin Chem Lab Med 2020; 58:1819-1827. [PMID: 32238601 DOI: 10.1515/cclm-2019-0292] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Accepted: 02/24/2020] [Indexed: 12/16/2022]
Abstract
Background Growing evidence reports an association between inflammatory markers, obesity and blood pressure (BP). Specifically, the intergenic single nucleotide polymorphism (SNP) rs7556897T > C (MAF = 0.34) located between SLC19A3 and the CCL20 was shown to be associated with chronic inflammatory diseases. In addition, CCL20 expression was found increased in pancreatic islets of obese rodents and human pancreatic β cells under the influence of inflammation. In this study, we hypothesized that SNP rs7556897 could affect BP levels, thus providing a link between inflammation, BP and obesity. Methods BP was measured under supine position with a manual sphygmomanometer; values reported were the means of three readings. We analyzed rs7556897 in 577 normal weight and 689 obese French children. Using real-time polymerase chain reaction (PCR), we quantified CCL20 and SLC19A3 expression in adipose tissue and peripheral blood mononuclear cells (PBMCs) of normal weight and overweight children. Results The rs7556897C allele was negatively associated with diastolic BP in normal weight children (β = -0.012 ± 0.004, p = 0.006) but positively associated in obese children (β = 2.178 ± 0.71, p = 0.002). A significant interaction between rs7556897T > C and the obesity status (obese or normal weight) was detected (β = 3.49, p = 9.79 × 10-5) for BP in a combined population analysis. CCL20 mRNA was only expressed in the adipose tissue of overweight children, and its expression levels were 10.7× higher in PBMCs of overweight children than normal weight children. Finally, CCL20 mRNA levels were positively associated with rs7556897T > C in PBMCs of 58 normal weight children (β = 0.43, p = 0.002). SLC19A3 was not expressed in PBMCs, and in adipose tissue, it showed same levels of expression in normal weight and overweight children. The gene expression results may highlight a specific involvement of CCL20 via communicating obesity/inflammation pathways that regulate BP. Conclusions Childhood obesity reverses the effect of rs7556897T > C on diastolic BP, possibly via the modulation of CCL20 expression levels.
Collapse
Affiliation(s)
- Said El Shamieh
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France.,Department of Medical Laboratory Sciences, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon
| | - Maria G Stathopoulou
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| | - Amélie Bonnefond
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France.,CNRS 8199-University Lille North of France, Institut Pasteur de Lille, Lille, France
| | - Ndeye Coumba Ndiaye
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| | - Cécile Lecoeur
- CNRS 8199-University Lille North of France, Institut Pasteur de Lille, Lille, France
| | - David Meyre
- CNRS 8199-University Lille North of France, Institut Pasteur de Lille, Lille, France.,Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
| | - Sébastien Dadé
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| | - Pia Chedid
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| | - Ali Salami
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France.,Rammal Hassan Rammal Research Laboratory, Physio-toxicity (PhyTox) Research Group, Lebanese University, Faculty of Sciences (V), Nabatieh, Lebanon
| | - Payman Shahabi
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| | - George V Dedoussis
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France.,Department of Nutrition - Dietetics, Harokopio University, Athens, Greece
| | - Philippe Froguel
- CNRS 8199-University Lille North of France, Institut Pasteur de Lille, Lille, France.,Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, UK
| | - Sophie Visvikis-Siest
- Research Unit EA_1122; IGE-PCV - Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire, Université de Lorraine, Faculté de Pharmacie, Nancy, France
| |
Collapse
|
6
|
Gorenjak V, Vance DR, Dade S, Stathopoulou MG, Doherty L, Xie T, Murray H, Masson C, Lamont J, Fitzgerald P, Visvikis-Siest S. Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration. Clin Epigenetics 2020; 12:79. [PMID: 32503626 PMCID: PMC7273671 DOI: 10.1186/s13148-020-00874-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Accepted: 05/26/2020] [Indexed: 12/21/2022] Open
Abstract
Introduction Vascular endothelial growth factor A (VEGF-A) is a chemokine that induces proliferation and migration of vascular endothelial cells and is essential for both physiological and pathological angiogenesis. It is known for its high heritability (> 60%) and involvement in most common morbidities, which makes it a potentially interesting biomarker. Large GWAS studies have already assessed polymorphisms related to VEGF-A. However, no previous research has provided epigenome-wide insight in regulation of VEGF-A. Methods VEGF-A concentrations of healthy participants from the STANISLAS Family Study (n = 201) were comprehensively assessed for association with DNA methylation. Genome-wide DNA methylation profiles were determined in whole blood DNA using the 450K Infinium BeadChip Array (Illumina). VEGF-A concentration in PBMC extracts was detected using a high-sensitivity multiplex Cytokine Array (Randox Laboratories, UK). Results Epigenome-wide association analysis identified 41 methylation sites significantly associated with VEGF-A concentrations derived from PBMC extracts. Twenty CpG sites within 13 chromosomes reached Holm-Bonferroni significance. Significant values ranged from P = 1.08 × 10−7 to P = 5.64 × 10−15. Conclusion This study exposed twenty significant CpG sites linking DNA methylation to VEGF-A concentration. Methylation detected in promoter regions, such as TPX2 and HAS-1, could explain previously reported associations with the VEGFA gene. Methylation may also help in the understanding of the regulatory mechanisms of other genes located in the vicinity of detected CpG sites.
Collapse
Affiliation(s)
- Vesna Gorenjak
- IGE-PCV, Inserm, Université de Lorraine, F-54000, Nancy, France
| | - Dwaine R Vance
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, UK
| | - Sébastien Dade
- IGE-PCV, Inserm, Université de Lorraine, F-54000, Nancy, France
| | | | - Lauren Doherty
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, UK
| | - Ting Xie
- IGE-PCV, Inserm, Université de Lorraine, F-54000, Nancy, France
| | - Helena Murray
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, UK
| | | | - John Lamont
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, UK
| | - Peter Fitzgerald
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, UK
| | - Sophie Visvikis-Siest
- IGE-PCV, Inserm, Université de Lorraine, F-54000, Nancy, France. .,Department of Internal Medicine and Geriatrics, CHU Technopôle Nancy-Brabois, Rue du Morvan, F-54511, Vandoeuvre-lès-, Nancy, France. .,INSERM UMR U1122, IGE-PCV, Faculté de Pharmacie-Université de Lorraine, 30 rue Lionnois, 54000, Nancy, France.
| |
Collapse
|
7
|
Xie T, Stathopoulou MG, Akbar S, Oster T, Siest G, Yen FT, Visvikis-Siest S. Effect of LSR polymorphism on blood lipid levels and age-specific epistatic interaction with the APOE common polymorphism. Clin Genet 2019; 93:846-852. [PMID: 29178324 DOI: 10.1111/cge.13181] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2017] [Revised: 11/18/2017] [Accepted: 11/21/2017] [Indexed: 12/28/2022]
Abstract
The lipolysis stimulated lipoprotein receptor (LSR) is an apolipoprotein (Apo) B and ApoE receptor that participates in the removal of triglyceride-rich lipoproteins during the postprandial phase. LSR gene is located upstream of APOE, an important risk factor for cardiovascular disease (CVD). Since the APOE common polymorphism significantly affects the variability of lipid metabolism, this study aimed to determine the potential impact of a functional SNP rs916147 in LSR gene on lipid traits in healthy subjects and to investigate potential epistatic interaction between LSR and APOE. Unrelated healthy adults (N = 432) and children (N = 328, <18 years old) from the STANISLAS Family Study were used. Age-specific epistasis was observed between APOE and LSR, reversing the protective effect of APOE ε2 allele on cholesterol, ApoE and low-density lipoprotein levels (β: .114, P: .777 × 10-8 , β: .125, P: .639 × 10-3 , β: .059, P: .531 × 10-3 , respectively). This interaction was verified in an independent adult population (n = 1744). These results highlight the importance of the LSR polymorphism and reveal the existence of complex molecular links between LSR and ApoE for the regulation of lipid levels, revealing potential new pathways of interest in type III hyperlipidemia and its involvement in CVD pathology.
Collapse
Affiliation(s)
- T Xie
- UMR INSERM, Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Université de Lorraine, Nancy, France
| | - M G Stathopoulou
- UMR INSERM, Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Université de Lorraine, Nancy, France
| | - S Akbar
- UMR INSERM, Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Université de Lorraine, Nancy, France.,EA3998 INRA USC 0340 UR AFPA, Université de Lorraine, Vandœuvre-lès-Nancy, France
| | - T Oster
- EA3998 INRA USC 0340 UR AFPA, Université de Lorraine, Vandœuvre-lès-Nancy, France
| | - G Siest
- UMR INSERM, Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Université de Lorraine, Nancy, France
| | - F T Yen
- EA3998 INRA USC 0340 UR AFPA, Université de Lorraine, Vandœuvre-lès-Nancy, France
| | - S Visvikis-Siest
- UMR INSERM, Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Université de Lorraine, Nancy, France.,Department of Internal Medicine and Geriatrics, CHU Nancy-Brabois, Nancy, France
| |
Collapse
|
8
|
Gorenjak V, Vance DR, Petrelis AM, Stathopoulou MG, Dadé S, Shamieh SE, Murray H, Masson C, Lamont J, Fitzgerald P, Visvikis-Siest S. Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population. PLoS One 2019; 14:e0220902. [PMID: 31419243 PMCID: PMC6697334 DOI: 10.1371/journal.pone.0220902] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Accepted: 07/25/2019] [Indexed: 01/09/2023] Open
Abstract
Background Vascular endothelial growth factor (VEGF) is a signal protein, implicated in various physiological and pathophysiological processes together with other common inflammatory biomarkers. However, their associations have not yet been fully elucidated. In the present study, we investigated associations between VEGF and four specific VEGF mRNA isoforms with levels of 11 inflammation molecules, derived from peripheral blood mononuclear cells (PBMCs) extracts. Methods Healthy participants from the STANISLAS Family Study (n = 285) were included. Levels of VEGF (four mRNA isoforms and protein levels) and inflammatory molecules (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, INF-γ, TNF-α, MCP-1, EGF) were measured in PBMCs extracts. Multiple regression analyses were performed, adjusted for age and gender. Results The analyses revealed significant associations between VEGF protein levels and levels of IL-4 (β = 0.028, P = 0.013), MCP-1 (β = 0.015, P<0.0001) and EGF (β = 0.017, P<0.0001). Furthermore, mRNA isoform VEGF165 was associated with MCP-1 and IL-1α (P = 0.002 and P = 0.008, respectively); and mRNA isoform VEGF189 was associated with IL-4 and IL-6 (P = 0.019 and P = 0.034, respectively). Conclusions To our knowledge, the present study represents the first investigation that successfully demonstrates links between VEGF protein levels and inflammatory molecules levels derived from PBMCs extracts and identifies associations between specific VEGF mRNA isoforms and inflammatory molecules. Impact These findings provide novel insights that may assist in the development of new tissue and mRNA isoform specific measurements of VEGF levels, which may positively contribute to predicting the risk of common complex diseases and response of currently used anti-VEGF agents, and developing of novel targeted therapies for VEGF-related pathophysiology.
Collapse
Affiliation(s)
| | - Dwaine R. Vance
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, United Kingdom
| | | | | | | | - Said El Shamieh
- Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon
| | - Helena Murray
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, United Kingdom
| | | | - John Lamont
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, United Kingdom
| | - Peter Fitzgerald
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, United Kingdom
| | - Sophie Visvikis-Siest
- Université de Lorraine, Inserm, IGE-PCV, Nancy, France
- Department of Internal Medicine and Geriatrics, CHU Technopôle Nancy-Brabois, Rue du Morvan, Vandoeuvre-lès-Nancy, France
- * E-mail:
| |
Collapse
|
9
|
Kazmi N, Koda Y, Ndiaye NC, Visvikis-Siest S, Morton MJ, Gaunt TR, Galea I. Genetic determinants of circulating haptoglobin concentration. Clin Chim Acta 2019; 494:138-142. [PMID: 30898509 PMCID: PMC6541910 DOI: 10.1016/j.cca.2019.03.1617] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Accepted: 03/17/2019] [Indexed: 01/15/2023]
Abstract
Haptoglobin (Hp) is a major plasma acute-phase glycoprotein, which binds free haemoglobin to neutralize its toxicity. The HP gene exists as two copy number variants (CNV), Hp1 and HP2, which differ in two ways: serum Hp level and functional differences in Hp protein products. Both mechanisms may underlie the HP CNV's influence on susceptibility and/or outcome in several diseases. A single nucleotide polymorphism rs2000999 has also been associated with serum Hp level. In a meta-analysis of three studies from England, France and Japan, with a combined sample size of 1210 participants, we show that rs2000999's effect on circulating Hp level is independent from that of the HP CNV. The combined use of rs2000999 and the HP CNV can be an important genetic epidemiological tool to discriminate between the two potential mechanisms underlying differences between HP1 and HP2 alleles.
Collapse
Affiliation(s)
- Nabila Kazmi
- MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - Yoshiro Koda
- Department of Forensic Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan
| | | | | | - Matthew J Morton
- Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, UK
| | - Tom R Gaunt
- MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - Ian Galea
- Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, UK.
| |
Collapse
|
10
|
Ferreira JP, Girerd N, Bozec E, Mercklé L, Pizard A, Bouali S, Eby E, Leroy C, Machu JL, Boivin JM, Lamiral Z, Rossignol P, Zannad F. Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France. Int J Epidemiol 2019; 47:395-395j. [PMID: 29220499 DOI: 10.1093/ije/dyx240] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2017] [Indexed: 01/16/2023] Open
Affiliation(s)
- João Pedro Ferreira
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France.,Department of Physiology and Cardiothoracic Surgery, University of Porto, Porto, Portugal
| | - Nicolas Girerd
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Erwan Bozec
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Ludovic Mercklé
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Anne Pizard
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Sanae Bouali
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Elise Eby
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Céline Leroy
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Jean-Loup Machu
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Jean-Marc Boivin
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Zohra Lamiral
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Patrick Rossignol
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Faiez Zannad
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| |
Collapse
|
11
|
Epigenome-Wide Association Study (EWAS) of Blood Lipids in Healthy Population from STANISLAS Family Study (SFS). Int J Mol Sci 2019; 20:ijms20051014. [PMID: 30813608 PMCID: PMC6429274 DOI: 10.3390/ijms20051014] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2019] [Revised: 02/10/2019] [Accepted: 02/21/2019] [Indexed: 12/11/2022] Open
Abstract
Epigenome-Wide Association Studies (EWAS) are furthering our knowledge of epigenetic modifications involved in the regulation of lipids’ metabolism. Furthermore, epigenetic patterns associated with lipid levels may play an important role in predicting the occurrence of cardiovascular events. To further investigate the relationship between methylation status and lipids, we performed an EWAS in 211 individuals from the STANISLAS Family study (SFS). Methylation at two CpG sites (PRKAG2; p = 1.39 × 10−8; KREMEN2; p = 5.75 × 10−9) were significantly associated with lipidomic profiles. Replication was sought in adipose tissue where one probe, cg08897188, was found to be nominally significant (KREMEN2; p = 0.0196). These results could provide new insight in the mechanisms underlying cardiovascular diseases and contribute to new therapeutic interventions.
Collapse
|
12
|
Coombes BJ, Basu S, McGue M. A linear mixed model framework for gene-based gene-environment interaction tests in twin studies. Genet Epidemiol 2018; 42:648-663. [PMID: 30203856 DOI: 10.1002/gepi.22150] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2017] [Revised: 04/25/2018] [Accepted: 04/30/2018] [Indexed: 02/03/2023]
Abstract
Interaction between genes and environments (G×E) can be well investigated in families due to the shared genes and environment among family members. However, the majority of the current tests of G×E interaction between a set of variants and an environment are only suitable for studies with unrelated subjects. In this paper, we extend several G×E interaction tests to a linear mixed model framework to study interaction between a set of correlated environments and a candidate gene in families. The correlated environments can either be modeled separately or jointly in one model. We demonstrate theoretically that the tests developed by modeling correlated environments separately are valid and present a computationally fast alternative to detect G×E interaction in families. For either strategy, we propose treating the genetic main effects as a random effect to reduce the number of main-effect parameters and thus improve the power to detect interactions. Additionally, we propose a generalization of a test of interaction that adaptively sums the interactions using a sequential algorithm. This generalized set of tests, referred to as the sequential algorithm for the sum of powered score (Seq-SPU) family of tests, can be expressed as a weighted version of the SPU. We find that the adaptive version of our test, Seq-aSPU, can outperform aSPU in cases where the interactions effects are in opposite directions. We applied these methods to the Minnesota Center for Twin and Family Research data set and found one significant gene in interaction with four psychosocial environmental factors affecting the alcohol consumption among the twins.
Collapse
Affiliation(s)
- Brandon J Coombes
- Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota
| | - Saonli Basu
- Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota
| | - Matt McGue
- Department of Psychology, School of Public Health, University of Minnesota, Minneapolis, Minnesota
| |
Collapse
|
13
|
Gorenjak V, Aldasoro Arguinano AA, Dadé S, Stathopoulou MG, Vance DR, Masson C, Visvikis-Siest S. The polymorphism rs6918289 located in the downstream region of the TREM2 gene is associated with TNF-α levels and IMT-F. Sci Rep 2018; 8:7160. [PMID: 29740051 PMCID: PMC5940861 DOI: 10.1038/s41598-018-25553-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2017] [Accepted: 04/24/2018] [Indexed: 01/05/2023] Open
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is known for its anti-inflammatory properties during the immune response, and influences negatively on TNF-α expression levels. Genetic epidemiology studies have identified polymorphisms located in the TREM2 gene associated with neurodegenerative and chronic inflammatory diseases. TREM2 levels have been observed to affect plasma levels of TNF-α and plaque stability in symptomatic and asymptomatic patients with carotid stenosis. In this study, we investigated polymorphisms located in the TREM2 gene region and association with TNF-α levels and the intima media thickness of the femoral artery. The discovery population from the STANISLAS Family Study comprised of 809 individuals, whereas the replication population utilized an independent cohort of French origin (n = 916). Our results suggest that the minor allele (T) of SNP rs6918289 is positively associated with elevated plasma levels of TNF-α in discovery and replication populations (P = 0.0026, SE = 0.04 and P = 0.023, SE = 0.09, respectively), including femoral artery thickness in the discovery cohort (P = 0.026, SE = 0.009). Results indicate that rs6918289 may be considered as a risk factor for inflammatory diseases and could be used in stratified medicine with patients diagnosed with chronic inflammatory-related conditions, such as atherosclerosis.
Collapse
Affiliation(s)
- Vesna Gorenjak
- Université de Lorraine, Inserm, IGE-PCV, F-54000, Nancy, France
| | | | - Sébastien Dadé
- Université de Lorraine, Inserm, IGE-PCV, F-54000, Nancy, France
| | | | - Dwaine R Vance
- Randox Laboratories Limited, Crumlin, Co. Antrim, Northern Ireland, United Kingdom
| | | | - Sophie Visvikis-Siest
- Université de Lorraine, Inserm, IGE-PCV, F-54000, Nancy, France. .,Department of Internal Medicine and Geriatrics, CHU Technopôle Nancy-Brabois, Rue du Morvan, F-54511, Vandoeuvre-lès-Nancy, France.
| |
Collapse
|
14
|
Stathopoulou MG, Xie T, Ruggiero D, Chatelin J, Rancier M, Weryha G, Kurth MJ, Aldasoro Arguinano AA, Gorenjak V, Petrelis AM, Dagher G, Dedoussis G, Deloukas P, Lamont J, Marc J, Simmaco M, Schaik RHNV, Innocenti F, Merlin JL, Schneider J, Alizadeh BZ, Ciullo M, Seshadri S, Visvikis-Siest S. A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium. Clin Chem Lab Med 2018; 56:83-86. [PMID: 29087954 DOI: 10.1515/cclm-2017-0838] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2017] [Accepted: 09/19/2017] [Indexed: 11/15/2022]
Affiliation(s)
- Maria G Stathopoulou
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | - Ting Xie
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | - Daniela Ruggiero
- Institute of Genetics and Biophysics, National Research Council of Italy, Naples, Italy
| | - Jerome Chatelin
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | - Marc Rancier
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | - George Weryha
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | | | - Alex-Ander Aldasoro Arguinano
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | - Vesna Gorenjak
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | - Alexandros M Petrelis
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | - Georges Dagher
- Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)/INSERM US 13, BIOBANQUES, Paris, France
| | - George Dedoussis
- Department of Nutrition Dietetics, Harokopio University of Athens, Athens, Greece
| | | | | | - Janja Marc
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| | | | - Ron H N van Schaik
- European Society of Pharmacogenomics and Personalised Therapy (ESPT), Nancy, France
| | | | - Jean-Louis Merlin
- Institut de Cancérologie de Lorraine et Université de Lorraine, Vandoeuvre les Nancy, France
| | | | - Behrooz Ziad Alizadeh
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Marina Ciullo
- Institute of Genetics and Biophysics, National Research Council of Italy, Naples, Italy.,IRCCS Neuromed, Pozzilli, Isernia, Italy
| | - Sudha Seshadri
- Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - Sophie Visvikis-Siest
- UMR INSERM U1122; IGE-PCV "Gene-Environment Interactions in Cardio-Vascular Physiopathology", University of Lorraine, Nancy, France
| | | |
Collapse
|
15
|
Aldasoro Arguinano AA, Dadé S, Stathopoulou M, Derive M, Coumba Ndiaye N, Xie T, Masson C, Gibot S, Visvikis-Siest S. TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin. PLoS One 2017; 12:e0182226. [PMID: 28771614 PMCID: PMC5542552 DOI: 10.1371/journal.pone.0182226] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2017] [Accepted: 07/15/2017] [Indexed: 01/01/2023] Open
Abstract
High levels of TREM-1 are associated with cardiovascular and inflammatory diseases risks and the most recent studies have showed that TREM-1 deletion or blockade is associated with up to 60% reduction of the development of atherosclerosis. So far, it is unknown whether the levels of TREM-1 protein are genetically regulated. Moreover, TREM family receptors have been suggested to regulate the cellular adhesion process. The goal of this study was to investigate whether polymorphisms within TREM-1 are regulating the variants of serum TREM-1 levels and the expression levels of their mRNA. Furthermore, we aimed to point out associations between polymorphisms on TREM-1 and blood levels of selectins. Among the 10 SNPs studied, the minor allele T of rs2234246, was associated with increased sTREM-1 in the discovery population (p-value = 0.003), explaining 33% of its variance, and with increased levels of mRNA (p-value = 0.007). The same allele was associated with increased soluble L-selectin levels (p-value = 0.011). The higher levels of sTREM-1 and L-selectin were confirmed in the replication population (p-value = 0.0007 and p-value = 0.018 respectively). We demonstrated for the first time one SNP on TREM-1, affecting its expression levels. These novel results, support the hypothesis that TREM-1 affects monocytes extravasation and accumulation processes leading to atherogenesis and atherosclerotic plaque progression, possibly through increased inflammation and subsequent higher expression of sL-selectin.
Collapse
Affiliation(s)
- Alex-Ander Aldasoro Arguinano
- UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardiovasculaire’, Faculté de Pharmacie–Université de Lorraine, Nancy, France
| | - Sébastien Dadé
- UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardiovasculaire’, Faculté de Pharmacie–Université de Lorraine, Nancy, France
| | - Maria Stathopoulou
- UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardiovasculaire’, Faculté de Pharmacie–Université de Lorraine, Nancy, France
| | | | - Ndeye Coumba Ndiaye
- UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardiovasculaire’, Faculté de Pharmacie–Université de Lorraine, Nancy, France
| | - Ting Xie
- UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardiovasculaire’, Faculté de Pharmacie–Université de Lorraine, Nancy, France
| | - Christine Masson
- UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardiovasculaire’, Faculté de Pharmacie–Université de Lorraine, Nancy, France
| | | | - Sophie Visvikis-Siest
- UMR INSERM U1122; IGE-PCV ‘Interactions Gène-Environnement en Physiopathologie Cardiovasculaire’, Faculté de Pharmacie–Université de Lorraine, Nancy, France
- Department of Internal Medicine and Geriatrics, CHU Technopôle Nancy-Brabois, Rue du Morvan, Vandoeuvre-lès-Nancy, France
- * E-mail:
| |
Collapse
|
16
|
Gbadoe KM, Berdouzi N, Aguiñano AAA, Ndiaye NC, Visvikis-Siest S. Cardiovascular diseases-related GNB3 C825T polymorphism has a significant sex-specific effect on serum soluble E-selectin levels. JOURNAL OF INFLAMMATION-LONDON 2016; 13:39. [PMID: 27990099 PMCID: PMC5148858 DOI: 10.1186/s12950-016-0146-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Accepted: 12/02/2016] [Indexed: 12/20/2022]
Abstract
Background The C825T polymorphism (rs5443) of the Guanine Nucleotide-Binding protein subunit β3 (GNB3) gene has been associated with obesity, essential hypertension, atherosclerosis, coronary diseases, and cerebrovascular events, but with some sex-specific effects. Its association with inflammatory mediators such as cell adhesion molecules has not been studied, although they are heavily involved in cardiovascular diseases’ (CVDs) processes. The aim of our study was then to investigate a possible sex-specific effect of the GNB3 C825T polymorphism on serum soluble cell adhesion molecules such as E, P and L-selectins (sE, sP and sL-selectins). Results Participants were from the STANISLAS Family Study and were free of chronic disease as CVDs or cancer. We included in total 771 subjects aged 6 to 58 years (391 males (50.71%) and 380 females (49.29%)). No significant association of rs5443 was observed in the whole population with serum sE, sP and sL-selectins after adjusting for age, sex, body mass index, systolic blood pressure, anti-inflammatory drugs and hormonal drugs consumption. A significant interaction of rs5443 was observed with sex for sE-selectin (p < 0.001), but not for sP and sL-selectins. After adjusting for covariables, the T allele was significantly associated with an additive increase effect on serum sE-selectin levels in males (β = 5.03 ± 2.18; p = 0.020), while a significant additive decrease effect was observed in females (β =−4.46 ± 2.06; p = 0.030). These associations stayed significant after correction for multiple tests (p = 0.045 in males and in females). The additive phenotypic variance was 21.54% in males versus 1.91% in females. Conclusions In our Caucasian population, the GNB3 C825T polymorphism showed a significant sex-specific effect on serum sE-selectin levels, with a disadvantage for males, as increased sE-selectin levels has been associated with CVDs outcomes. The T allele has been previously associated with the same CVDs as increased sE-selectin, but more often in males. The link we observed between this polymorphism and E-selectin is then consistent with previous findings, and helps to better understand the deleterious effect of the GNB3 825 T allele on CVDs outcomes in males. We revealed in this study an important pathway through which the GNB3 gene induces CVDs’ outcomes.
Collapse
Affiliation(s)
- Kokoè Mélinda Gbadoe
- UMR INSERM U1122; IGE-PCV "Interaction Gène-Environnement en Physiopathologie CardioVasculaire", Faculté de Pharmacie, Université de Lorraine, Nancy, F-54000 France
| | - Nazha Berdouzi
- UMR INSERM U1122; IGE-PCV "Interaction Gène-Environnement en Physiopathologie CardioVasculaire", Faculté de Pharmacie, Université de Lorraine, Nancy, F-54000 France
| | - Alex-Ander Aldasoro Aguiñano
- UMR INSERM U1122; IGE-PCV "Interaction Gène-Environnement en Physiopathologie CardioVasculaire", Faculté de Pharmacie, Université de Lorraine, Nancy, F-54000 France
| | - Ndeye Coumba Ndiaye
- UMR INSERM U1122; IGE-PCV "Interaction Gène-Environnement en Physiopathologie CardioVasculaire", Faculté de Pharmacie, Université de Lorraine, Nancy, F-54000 France
| | - Sophie Visvikis-Siest
- UMR INSERM U1122; IGE-PCV "Interaction Gène-Environnement en Physiopathologie CardioVasculaire", Faculté de Pharmacie, Université de Lorraine, Nancy, F-54000 France
| |
Collapse
|
17
|
Saleh A, Stathopoulou MG, Dadé S, Ndiaye NC, Azimi-Nezhad M, Murray H, Masson C, Lamont J, Fitzgerald P, Visvikis-Siest S. Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults. BMC MEDICAL GENETICS 2015; 16:90. [PMID: 26437765 PMCID: PMC4594922 DOI: 10.1186/s12881-015-0234-6] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/21/2014] [Accepted: 09/23/2015] [Indexed: 11/10/2022]
Abstract
BACKGROUND Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis. The aim was to assess the genetic connections between the angiogenesis-related NOS3, CD14, MMP3, IL4R, IL4 genes and VEGF expression and plasma levels. METHODS The associations between VEGF plasma levels with the polymorphisms of NOS3, CD14, MMP3, IL4R, and IL4 were assessed in 403 healthy unrelated adults. The epistatic and environmental interactions were explored, including four VEGF-related polymorphisms previously identified. The VEGF expression in peripheral blood mononuclear cells was quantified (n = 65) for the VEGF121, VEGF145, VEGF165, and VEGF189 isoforms. RESULTS The polymorphism rs1799983 of NOS3 was associated with the sum of all VEGF isoforms mRNA levels (P = 0.032) and VEGF145 (P = 0.033). Rs1800779 of NOS3 interacted with rs3918226 of the same gene and with the rs2569190 of CD14 (P = 0.022, P = 0.042, respectively) for VEGF plasma levels. Other epistatic interactions included the rs1801275 of IL4R with the rs6921438 (VEGF-related variant) and rs3025058 of MMP3 (P = 0.042, P = 0.010 respectively) and the rs2569190 of CD14 with the rs3025058 of MMP3 (P = 0.0119). We also identified an interaction of rs1800779 with obesity, high-density lipoprotein cholesterol and triglycerides (P = 0.018, P = 0.005, P = 0.043, respectively) as well as the interaction of rs6921438 with hypertension (P = 0.028). CONCLUSIONS Our findings indicated that genetic variants of NOS3, CD14, MMP3 and IL4R are implicated in the determination of VEGF expression and plasma levels. Thus, they support the hypothesis that in physiological conditions there are complex biological relationships between pathways (such as angiogenesis and inflammation), which are involved in the development of chronic diseases.
Collapse
Affiliation(s)
- Abdelsalam Saleh
- UMR INSERM U 1122, IGE-PCV "Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire", Université de Lorraine, Nancy, F-54000, France.
| | - Maria G Stathopoulou
- UMR INSERM U 1122, IGE-PCV "Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire", Université de Lorraine, Nancy, F-54000, France.
| | - Sébastien Dadé
- UMR INSERM U 1122, IGE-PCV "Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire", Université de Lorraine, Nancy, F-54000, France.
| | - Ndeye Coumba Ndiaye
- UMR INSERM U 1122, IGE-PCV "Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire", Université de Lorraine, Nancy, F-54000, France.
| | - Mohsen Azimi-Nezhad
- UMR INSERM U 1122, IGE-PCV "Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire", Université de Lorraine, Nancy, F-54000, France. .,Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
| | | | - Christine Masson
- UMR INSERM U 1122, IGE-PCV "Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire", Université de Lorraine, Nancy, F-54000, France.
| | | | | | - Sophie Visvikis-Siest
- UMR INSERM U 1122, IGE-PCV "Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire", Université de Lorraine, Nancy, F-54000, France. .,Geriatric Service, University Hospital of Nancy, Nancy, France.
| |
Collapse
|
18
|
Jacobs L, Thijs L, Jin Y, Zannad F, Mebazaa A, Rouet P, Pinet F, Bauters C, Pieske B, Tomaschitz A, Mamas M, Diez J, McDonald K, Cleland JGF, Brunner-La Rocca HP, Heymans S, Latini R, Masson S, Sever P, Delles C, Pocock S, Collier T, Kuznetsova T, Staessen JA. Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database. J Biomed Res 2014; 28:349-59. [PMID: 25332706 PMCID: PMC4197385 DOI: 10.7555/jbr.28.20140045] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2014] [Revised: 03/31/2014] [Accepted: 06/24/2014] [Indexed: 01/06/2023] Open
Abstract
Heart failure is common in older people and its prevalence is increasing. The Heart ‘omics’ in AGEing (HOMAGE) project aims to provide a biomarker approach that will improve the early diagnosis of heart failure. A large clinical database, based on (1) prospective population studies or (2) cross-sectional, prospective studies or randomized controlled trials (RCTs) of patients at risk for or with overt cardiovascular disease will be constructed to determine most promising ‘omics’-based biomarkers to identify the risk of developing heart failure and/or comorbidities. Population studies, patient cohorts and RCTs are eligible for inclusion in the common database, if they received ethical approval to obtain and share data and have baseline information on cardiovascular risk factors. Currently, the HOMAGE database includes 43,065 subjects, from 20 studies in eight European countries, including healthy subjects from three population studies in France, Belgium and Italy (n = 7,124), patients with heart failure (n = 4,312) from four cohorts in the UK, Spain and Switzerland and patients at high risk for cardiovascular disease (n = 31,629) in 13 cohorts. It is anticipated that more partners will join the consortium and enlarge the pooled data. This large merged database will be a useful resource with which to identify candidate biomarkers that play a role in the mechanism underlying the onset and progression of heart failure.
Collapse
Affiliation(s)
- Lotte Jacobs
- Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium
| | - Lutgarde Thijs
- Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium
| | - Yu Jin
- Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium
| | - Faiez Zannad
- Centre d'Investigation Clinique Pierre Drouin and U 961, Hypertension and Heart Failure Unit, Institut Lourrain du Coeur et des Vaisseaux, Inserm, Nancy, France
| | - Alexandre Mebazaa
- Department of Anesthesiology and Critical Care Medicine, InsermUMR-S942, Hôpital Lariboisière, Université Paris Diderot, Paris, France
| | - Philippe Rouet
- Equipe obésité et insuffisance cardiaque, Université UPS, Inserm I2MC, UMR 1048, Toulouse, France
| | | | | | - Burkert Pieske
- Department of Cardiology, Medical University Graz, Austria
| | | | - Mamas Mamas
- Cardiovascular Institute, University of Manchester, Manchester, UK
| | - Javier Diez
- Division of Cardiovascular Sciences, Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain
| | - Kenneth McDonald
- Heart Failure Unit, St Vincent's University Hospital, University College Dublin, Dublin, Ireland
| | | | | | - Stephane Heymans
- Center for Heart Failure Research, Department of Cardiology, Maastricht University, Netherlands
| | - Roberto Latini
- Department of Cardiovascular Research, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy
| | - Serge Masson
- Department of Cardiovascular Research, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy
| | - Peter Sever
- International Center for Circulatory Health, Imperial College London, UK
| | - Christian Delles
- Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, UK
| | - Stuart Pocock
- London School of Hygiene and Tropical Medicine, London, UK
| | | | - Tatiana Kuznetsova
- Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium
| | - Jan A Staessen
- Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium
| |
Collapse
|
19
|
Nivet-Antoine V, Labat C, El Shamieh S, Dulcire X, Cottart CH, Beaudeux JL, Zannad F, Visvikis-Siest S, Benetos A. Relationship between catalase haplotype and arterial aging. Atherosclerosis 2013; 227:100-5. [DOI: 10.1016/j.atherosclerosis.2012.12.015] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2012] [Revised: 10/23/2012] [Accepted: 12/16/2012] [Indexed: 10/27/2022]
|
20
|
Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population. Cytokine 2013. [DOI: 10.1016/j.cyto.2012.10.024] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
21
|
Ndiaye NC, Said ES, Stathopoulou MG, Siest G, Tsai MY, Visvikis-Siest S. Epistatic study reveals two genetic interactions in blood pressure regulation. BMC MEDICAL GENETICS 2013; 14:2. [PMID: 23298194 PMCID: PMC3599121 DOI: 10.1186/1471-2350-14-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 06/13/2012] [Accepted: 12/03/2012] [Indexed: 01/11/2023]
Abstract
Background Although numerous candidate gene and genome-wide association studies have been performed on blood pressure, a small number of regulating genetic variants having a limited effect have been identified. This phenomenon can partially be explained by possible gene-gene/epistasis interactions that were little investigated so far. Methods We performed a pre-planned two-phase investigation: in phase 1, one hundred single nucleotide polymorphisms (SNPs) in 65 candidate genes were genotyped in 1,912 French unrelated adults in order to study their two-locus combined effects on blood pressure (BP) levels. In phase 2, the significant epistatic interactions observed in phase 1 were tested in an independent population gathering 1,755 unrelated European adults. Results Among the 9 genetic variants significantly associated with systolic and diastolic BP in phase 1, some may act through altering the corresponding protein levels: SNPs rs5742910 (Padjusted≤0.03) and rs6046 (Padjusted =0.044) in F7 and rs1800469 (Padjusted ≤0.036) in TGFB1; whereas some may be functional through altering the corresponding protein structure: rs1800590 (Padjusted =0.028, SE=0.088) in LPL and rs2228570 (Padjusted ≤9.48×10-4) in VDR. The two epistatic interactions found for systolic and diastolic BP in the discovery phase: VCAM1 (rs1041163) * APOB (rs1367117), and SCGB1A1 (rs3741240) * LPL (rs1800590), were tested in the replication population and we observed significant interactions on DBP. In silico analyses yielded putative functional properties of the SNPs involved in these epistatic interactions trough the alteration of corresponding protein structures. Conclusions These findings support the hypothesis that different pathways and then different genes may act synergistically in order to modify BP. This could highlight novel pathophysiologic mechanisms underlying hypertension.
Collapse
Affiliation(s)
- Ndeye Coumba Ndiaye
- "Cardiovascular Genetics" Research Unit, EA-4373, University of Lorraine, 30 rue Lionnois - 54000, Nancy, France
| | | | | | | | | | | |
Collapse
|
22
|
Samara A, Herbeth B, Ndiaye NC, Fumeron F, Billod S, Siest G, Visvikis-Siest S. Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study. Nutrition 2012; 29:519-24. [PMID: 23274089 DOI: 10.1016/j.nut.2012.08.013] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2012] [Revised: 08/28/2012] [Accepted: 08/29/2012] [Indexed: 01/01/2023]
Abstract
OBJECTIVE We assessed the associations of total dairy products; milk, yogurt, and cottage cheese; cheese; and calcium with 5-y changes in components of the metabolic syndrome. METHODS Two hundred eighty-eight men and 300 women 28 to 60 y of age from the suivi temporaire annuel non invasif de la santé des lorrains assurés sociaux (STANISLAS) cohort completed at baseline a 3-d dietary record. Statistics were performed using multivariate regression analysis. RESULTS In men, no relation was found between the four dietary indices and components of the metabolic syndrome measured at baseline. Conversely, the consumption of milk, yogurt, and cottage cheese at entry was inversely associated with 5-y changes in glucose levels (P ≤ 0.05, P ≤ 0.01 for sex interaction) and positively with 5-y changes in high-density lipoprotein cholesterol (P ≤ 0.05). Higher calcium intakes were significantly related to a lower 5-y increase of the body mass index (BMI) and waist circumference in men (P ≤ 0.01, P ≤ 0.05 for sex interaction). In addition, changes in diastolic blood pressure were inversely associated with the consumption of milk, yogurt, and cottage cheese only in men with a normal BMI (P ≤ 0.05 for BMI interaction). In women, unlike men, associations were shown for some components measured at baseline: total dairy positively related to BMI and waist circumference; total dairy, milk, yogurt, and cottage cheese, and calcium were positively related to triacylglycerols and negatively to high-density lipoprotein cholesterol. However, no significant association was found for any 5-y-changes. CONCLUSION In men only, a higher consumption of dairy products was associated with positive changes in the metabolic profile in a 5-y period; a higher calcium consumption was associated with a lower 5-y increase of the BMI and waist circumference.
Collapse
Affiliation(s)
- Anastasia Samara
- EA 4373 "Génétique Cardiovasculaire", Faculté de Pharmacie, Université de Lorraine, Nancy, France
| | | | | | | | | | | | | |
Collapse
|
23
|
Stathopoulou MG, Bonnefond A, Ndiaye NC, Azimi-Nezhad M, El Shamieh S, Saleh A, Rancier M, Siest G, Lamont J, Fitzgerald P, Visvikis-Siest S. A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C. J Lipid Res 2012. [PMID: 23204297 DOI: 10.1194/jlr.p030551] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Vascular endothelial growth factor A (VEGFA) is among the most-significant stimulators of angiogenesis. Its effect on cardiovascular diseases and on the variation of related risk factors such as lipid parameters is considered important, although as yet unclear. Recently, we identified four common variants (rs6921438, rs4416670, rs6993770, and rs10738760) that explain up to 50% of the heritability of plasma VEGFA levels. In the present study, we aimed at assessing the contribution of these variants to the variation of blood lipid levels (including apoE, triglycerides, total cholesterol, low- and high-density lipoprotein cholesterol levels (LDL-C and HDL-C)] in healthy subjects. The effect of these single-nucleotide polymorphisms (SNPs) on lipid levels was assessed using linear regression in discovery and replication samples (n = 1,006 and n = 1,145; respectively), followed by a meta-analysis. Their gene×gene and gene×environment interactions were also assessed. SNP rs6921438 was associated with HDL-C (β = -0.08 mmol/l, P(overall) = 1.2 × 10(-7)) and LDL-C (β = 0.13 mmol/l, P(overall) = 1.5 × 10(-4)). We also identified a significant association between the interaction rs4416670×hypertension and apoE variation (P(overall) = 1.7 × 10(-5)). Therefore, our present study shows a common genetic regulation between VEGFA and cholesterol homeostasis molecules. The SNP rs6921438 is in linkage disequilibrium with variants located in an enhancer- and promoter-associated histone mark region and could have a regulatory effect in the expression of surrounding genes, including VEGFA.
Collapse
Affiliation(s)
- Maria G Stathopoulou
- Université de Lorraine, Génétique Cardio-vasculaire, EA-4373, Nancy, F-54000, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Shahabi P, Siest G, Herbeth B, Ndiaye NC, Visvikis-Siest S. Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999. Clin Chim Acta 2012; 413:1618-24. [DOI: 10.1016/j.cca.2012.04.033] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2012] [Revised: 04/23/2012] [Accepted: 04/29/2012] [Indexed: 11/28/2022]
|
25
|
Alcohol Consumption, Beverage Preference, and Diet in Middle-Aged Men from the STANISLAS Study. J Nutr Metab 2012; 2012:987243. [PMID: 23056930 PMCID: PMC3465914 DOI: 10.1155/2012/987243] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2012] [Revised: 08/08/2012] [Accepted: 09/02/2012] [Indexed: 11/28/2022] Open
Abstract
The question about differences in dietary patterns associated with beer, wine, and spirits is still unresolved. We used diet data from 423 middle-aged males of the STANISLAS Study. Using adjusted values for covariates, we observed a negative significant association between increasing alcohol intakes and the consumption of milk, yogurt, and fresh/uncured cheese, sugar and confectionery, vegetables and fruits, and a significant positive relationship with cheese, meat and organs, pork-butcher's meat, and potatoes. In addition, the first dietary pattern identified by factor analysis (characterized a more prudent diet) was inversely related to alcohol intakes. Conversely, when analyzing daily consumption of specific food groups and diet patterns according to beverage preference (wine, beer, and spirits), no significant difference was observed. In conclusion, in this sample of middle-aged French males, there was a linear trend between increasing alcohol intakes and worsening of quality of diet, while no difference was observed according to beverage preference.
Collapse
|
26
|
El Shamieh S, Ndiaye NC, Stathopoulou MG, Murray HA, Masson C, Lamont JV, Fitzgerald P, Benetos A, Visvikis-Siest S. Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels. PLoS One 2012; 7:e40777. [PMID: 22815813 PMCID: PMC3399862 DOI: 10.1371/journal.pone.0040777] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2012] [Accepted: 06/13/2012] [Indexed: 01/11/2023] Open
Abstract
Background Although numerous genetic studies have been performed, only 0.9% of blood pressure phenotypic variance has been elucidated. This phenomenon could be partially due to epistatic interactions. Our aim was to identify epistatic interaction(s) associated with blood pressure levels in a pre-planned two-phase approach. Methods and Results In a discovery cohort composed of 3,600 French individuals, we found rs6046A allele in F7 associated with decreased blood pressure levels (P≤3.7×10−3) and rs5355T allele in SELE associated with decreased diastolic blood pressure levels (P = 5×10−3). Both variants interacted in order to influence blood pressure levels (P≤0.048). This interaction was replicated with systolic blood pressure in 4,620 additional European individuals (P = 0.03). Similarly, in this replication cohort, rs6046A was associated with decreased blood pressure levels (P≤8.5×10−4). Furthermore, in peripheral blood mononuclear cells of a subsample of 90 supposed healthy individuals, we found rs6046A positively associated with NAMPT mRNA levels (P≤9.1×10−5), suggesting an eventual involvement of NAMPT expression in blood pressure regulation. Confirming this hypothesis, further transcriptomic analyses showed that increased NAMPT mRNA levels were positively correlated with ICAM1, SELL, FPR1, DEFA1-3, and LL-37 genes expression (P≤5×10−3). The last two mRNA levels were positively associated with systolic blood pressure levels (P≤0.01) and explained 4% of its phenotypic variation. Conclusion These findings reveal the importance of epistatic interactions in blood pressure genetics and give new insights for the role of inflammation in its complex regulation.
Collapse
Affiliation(s)
- Said El Shamieh
- Université de Lorraine, “Génétique Cardio-vasculaire”, EA-4373, Nancy, France
| | - Ndeye Coumba Ndiaye
- Université de Lorraine, “Génétique Cardio-vasculaire”, EA-4373, Nancy, France
| | | | | | - Christine Masson
- Université de Lorraine, “Génétique Cardio-vasculaire”, EA-4373, Nancy, France
| | - John V. Lamont
- Randox Laboratories Ltd, Crumlin, Antrim, United Kingdom
| | | | - Athanase Benetos
- INSERM U961, Université de Lorraine, Nancy, France
- CHU Nancy, Brabois, Service de Gériatrie, Nancy, France
| | - Sophie Visvikis-Siest
- Université de Lorraine, “Génétique Cardio-vasculaire”, EA-4373, Nancy, France
- CHU Nancy, Brabois, Service de Gériatrie, Nancy, France
- * E-mail:
| |
Collapse
|
27
|
El-Sayed Moustafa JS, Eleftherohorinou H, de Smith AJ, Andersson-Assarsson JC, Alves AC, Hadjigeorgiou E, Walters RG, Asher JE, Bottolo L, Buxton JL, Sladek R, Meyre D, Dina C, Visvikis-Siest S, Jacobson P, Sjöström L, Carlsson LMS, Walley A, Falchi M, Froguel P, Blakemore AIF, Coin LJM. Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity. Hum Mol Genet 2012; 21:3727-38. [PMID: 22595969 DOI: 10.1093/hmg/dds187] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Variable number tandem repeats (VNTRs) constitute a relatively under-examined class of genomic variants in the context of complex disease because of their sequence complexity and the challenges in assaying them. Recent large-scale genome-wide copy number variant mapping and association efforts have highlighted the need for improved methodology for association studies using these complex polymorphisms. Here we describe the in-depth investigation of a complex region on chromosome 8p21.2 encompassing the dedicator of cytokinesis 5 (DOCK5) gene. The region includes two VNTRs of complex sequence composition which flank a common 3975 bp deletion, all three of which were genotyped by polymerase chain reaction and fragment analysis in a total of 2744 subjects. We have developed a novel VNTR association method named VNTRtest, suitable for association analysis of multi-allelic loci with binary and quantitative outcomes, and have used this approach to show significant association of the DOCK5 VNTRs with childhood and adult severe obesity (P(empirical)= 8.9 × 10(-8) and P= 3.1 × 10(-3), respectively) which we estimate explains ~0.8% of the phenotypic variance. We also identified an independent association between the 3975 base pair (bp) deletion and obesity, explaining a further 0.46% of the variance (P(combined)= 1.6 × 10(-3)). Evidence for association between DOCK5 transcript levels and the 3975 bp deletion (P= 0.027) and both VNTRs (P(empirical)= 0.015) was also identified in adipose tissue from a Swedish family sample, providing support for a functional effect of the DOCK5 deletion and VNTRs. These findings highlight the potential role of DOCK5 in human obesity and illustrate a novel approach for analysis of the contribution of VNTRs to disease susceptibility through association studies.
Collapse
Affiliation(s)
- Julia S El-Sayed Moustafa
- Department of Genomics of Common Disease, School of Public Health Inperial College, London, W12 ONN, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Abstract
BACKGROUND Historically, models to describe disease were exclusively nature-based or nurture-based. Current theoretical models for complex conditions such as cardiovascular disease acknowledge the importance of both biologic and non-biologic contributors to disease. A critical feature is the occurrence of interactions between numerous risk factors for disease. The interaction between genetic (i.e., biologic, nature) and environmental (i.e. non-biologic, nurture) causes of disease is an important mechanism for understanding both the etiology and public health impact of cardiovascular disease. OBJECTIVES The purpose of this paper is to describe theoretical underpinnings of gene-environment interactions, models of interaction, methods for studying gene-environment interactions, and the related concept of interactions between epigenetic mechanisms and the environment. DISCUSSION Advances in methods for measurement of genetic predictors of disease have enabled an increasingly comprehensive understanding of the causes of disease. In order to fully describe the effects of genetic predictors of disease, it is necessary to place genetic predictors within the context of known environmental risk factors. The additive or multiplicative effect of the interaction between genetic and environmental risk factors is often greater than the contribution of either risk factor alone.
Collapse
Affiliation(s)
- Elena Flowers
- School of Nursing, Department of Physiologic Nursing, University of California, San Francisco 94143, USA.
| | | | | |
Collapse
|
29
|
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. PLoS One 2012; 7:e32327. [PMID: 22403646 PMCID: PMC3293812 DOI: 10.1371/journal.pone.0032327] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2011] [Accepted: 01/25/2012] [Indexed: 11/19/2022] Open
Abstract
Haptoglobin is an acute phase inflammatory marker. Its main function is to bind hemoglobin released from erythrocytes to aid its elimination, and thereby haptoglobin prevents the generation of reactive oxygen species in the blood. Haptoglobin levels have been repeatedly associated with a variety of inflammation-linked infectious and non-infectious diseases, including malaria, tuberculosis, human immunodeficiency virus, hepatitis C, diabetes, carotid atherosclerosis, and acute myocardial infarction. However, a comprehensive genetic assessment of the inter-individual variability of circulating haptoglobin levels has not been conducted so far. We used a genome-wide association study initially conducted in 631 French children followed by a replication in three additional European sample sets and we identified a common single nucleotide polymorphism (SNP), rs2000999 located in the Haptoglobin gene (HP) as a strong genetic predictor of circulating Haptoglobin levels (Poverall = 8.1×10−59), explaining 45.4% of its genetic variability (11.8% of Hp global variance). The functional relevance of rs2000999 was further demonstrated by its specific association with HP mRNA levels (β = 0.23±0.08, P = 0.007). Finally, SNP rs2000999 was associated with decreased total and low-density lipoprotein cholesterol in 8,789 European children (Ptotal cholesterol = 0.002 and PLDL = 0.0008). Given the central position of haptoglobin in many inflammation-related metabolic pathways, the relevance of rs2000999 genotyping when evaluating haptoglobin concentration should be further investigated in order to improve its diagnostic/therapeutic and/or prevention impact.
Collapse
|
30
|
Adiponectin Level and Gene Variability Are Obesity and Metabolic Syndrome Markers in a Young Population. Arch Med Res 2012; 43:145-53. [DOI: 10.1016/j.arcmed.2012.02.004] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2011] [Accepted: 01/16/2012] [Indexed: 12/11/2022]
|
31
|
Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z, Martinet D, Shen Y, Valsesia A, Beckmann ND, Thorleifsson G, Belfiore M, Bouquillon S, Campion D, De Leeuw N, De Vries BBA, Esko T, Fernandez BA, Fernández-Aranda F, Fernández-Real JM, Gratacòs M, Guilmatre A, Hoyer J, Jarvelin MR, Kooy FR, Kurg A, Le Caignec C, Männik K, Platt OS, Sanlaville D, Van Haelst MM, Villatoro Gomez S, Walha F, Wu BL, Yu Y, Aboura A, Addor MC, Alembik Y, Antonarakis SE, Arveiler B, Barth M, Bednarek N, Béna F, Bergmann S, Beri M, Bernardini L, Blaumeiser B, Bonneau D, Bottani A, Boute O, Brunner HG, Cailley D, Callier P, Chiesa J, Chrast J, Coin L, Coutton C, Cuisset JM, Cuvellier JC, David A, De Freminville B, Delobel B, Delrue MA, Demeer B, Descamps D, Didelot G, Dieterich K, Disciglio V, Doco-Fenzy M, Drunat S, Duban-Bedu B, Dubourg C, El-Sayed Moustafa JS, Elliott P, Faas BHW, Faivre L, Faudet A, Fellmann F, Ferrarini A, Fisher R, Flori E, Forer L, Gaillard D, Gerard M, Gieger C, Gimelli S, Gimelli G, Grabe HJ, Guichet A, Guillin O, Hartikainen AL, Heron D, Hippolyte L, Holder M, Homuth G, Isidor B, Jaillard S, Jaros Z, Jiménez-Murcia S, Joly Helas G, Jonveaux P, Kaksonen S, Keren B, Kloss-Brandstätter A, Knoers NVAM, Koolen DA, Kroisel PM, Kronenberg F, Labalme A, Landais E, Lapi E, Layet V, Legallic S, Leheup B, Leube B, Lewis S, Lucas J, Macdermot KD, Magnusson P, Marshall CR, Mathieu-Dramard M, Mccarthy MI, Meitinger T, Antonietta Mencarelli M, Merla G, Moerman A, Mooser V, Morice-Picard F, Mucciolo M, Nauck M, Coumba Ndiaye N, Nordgren A, Pasquier L, Petit F, Pfundt R, Plessis G, Rajcan-Separovic E, Paolo Ramelli G, Rauch A, Ravazzolo R, Reis A, Renieri A, Richart C, Ried JS, Rieubland C, Roberts W, Roetzer KM, Rooryck C, Rossi M, Saemundsen E, Satre V, Schurmann C, Sigurdsson E, Stavropoulos DJ, Stefansson H, Tengström C, Thorsteinsdóttir U, Tinahones FJ, Touraine R, Vallée L, Van Binsbergen E, Van Der Aa N, Vincent-Delorme C, Visvikis-Siest S, Vollenweider P, Völzke H, Vulto-Van Silfhout AT, Waeber G, Wallgren-Pettersson C, Witwicki RM, Zwolinksi S, Andrieux J, Estivill X, Gusella JF, Gustafsson O, Metspalu A, Scherer SW, Stefansson K, Blakemore AIF, Beckmann JS, Froguel P. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 2011; 478:97-102. [PMID: 21881559 PMCID: PMC3637175 DOI: 10.1038/nature10406] [Citation(s) in RCA: 309] [Impact Index Per Article: 23.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2011] [Accepted: 07/29/2011] [Indexed: 12/25/2022]
Abstract
Both obesity and being underweight have been associated with increased mortality. Underweight, defined as a body mass index (BMI) ≤ 18.5 kg per m(2) in adults and ≤ -2 standard deviations from the mean in children, is the main sign of a series of heterogeneous clinical conditions including failure to thrive, feeding and eating disorder and/or anorexia nervosa. In contrast to obesity, few genetic variants underlying these clinical conditions have been reported. We previously showed that hemizygosity of a ∼600-kilobase (kb) region on the short arm of chromosome 16 causes a highly penetrant form of obesity that is often associated with hyperphagia and intellectual disabilities. Here we show that the corresponding reciprocal duplication is associated with being underweight. We identified 138 duplication carriers (including 132 novel cases and 108 unrelated carriers) from individuals clinically referred for developmental or intellectual disabilities (DD/ID) or psychiatric disorders, or recruited from population-based cohorts. These carriers show significantly reduced postnatal weight and BMI. Half of the boys younger than five years are underweight with a probable diagnosis of failure to thrive, whereas adult duplication carriers have an 8.3-fold increased risk of being clinically underweight. We observe a trend towards increased severity in males, as well as a depletion of male carriers among non-medically ascertained cases. These features are associated with an unusually high frequency of selective and restrictive eating behaviours and a significant reduction in head circumference. Each of the observed phenotypes is the converse of one reported in carriers of deletions at this locus. The phenotypes correlate with changes in transcript levels for genes mapping within the duplication but not in flanking regions. The reciprocal impact of these 16p11.2 copy-number variants indicates that severe obesity and being underweight could have mirror aetiologies, possibly through contrasting effects on energy balance.
Collapse
Affiliation(s)
| | - Alexandre Reymond
- Centre de génomique intégrative
Université de Lausanne1015 Lausanne,CH
| | - Flore Zufferey
- Service de génétique médicale
CHU Vaudois1011 Lausanne,CH
| | - Louise Harewood
- Centre de génomique intégrative
Université de Lausanne1015 Lausanne,CH
| | - Robin G. Walters
- Department of Genomics of Common Disease
Imperial College LondonHammersmith hospital, London W12 0NN,GB
| | - Zoltán Kutalik
- Department of Medical Genetics
University of LausanneCH
- SIB, Swiss Institute of Bioinformatics
Swiss Institute of BioinformaticsQuartier Sorge - Batiment Genopode 1015 Lausanne Switzerland,CH
| | | | - Yiping Shen
- Laboratory Medicine
Children's Hospital BostonBoston, Massachusetts 02115,US
- Center for Human Genetic Research
Massachusetts General HospitalBoston, Massachusetts 02114,US
| | - Armand Valsesia
- Department of Medical Genetics
University of LausanneCH
- SIB, Swiss Institute of Bioinformatics
Swiss Institute of BioinformaticsQuartier Sorge - Batiment Genopode 1015 Lausanne Switzerland,CH
- Ludwig Institute for Cancer Research
Université de Lausanne1015 Lausanne,CH
| | | | | | - Marco Belfiore
- Service de génétique médicale
CHU Vaudois1011 Lausanne,CH
| | - Sonia Bouquillon
- Laboratoire de Génétique Médicale
Hôpital Jeanne de FlandreCHRU Lille59037 Lille Cedex,FR
| | - Dominique Campion
- Génétique médicale et fonctionnelle du cancer et des maladies neuropsychiatriques
INSERM : U614Université de RouenUFR de Medecine et de Pharmacie 22, Boulevard Gambetta 76183 Rouen cedex,FR
- Estonian Genome and Medicine
University of Tartu51010 Tartu,EE
| | - Nicole De Leeuw
- Department of human genetics
Radboud University Nijmegen Medical CentreNijmegen Centre for Molecular Life SciencesInstitute for Genetic and Metabolic Disorders6500 HB Nijmegen,NL
| | - Bert B. A. De Vries
- Department of human genetics
Radboud University Nijmegen Medical CentreNijmegen Centre for Molecular Life SciencesInstitute for Genetic and Metabolic Disorders6500 HB Nijmegen,NL
| | - Tõnu Esko
- Estonian Genome and Medicine
University of Tartu51010 Tartu,EE
- Institute of Molecular and Cell Biology
University of Tartu51010 Tartu,EE
| | - Bridget A. Fernandez
- Disciplines of Genetics and Medicine
Memorial University of NewfoundlandSt. John's Newfoundland,CA
| | - Fernando Fernández-Aranda
- IDIBELL, Department of Psychiatry
University Hospital of BellvitgeCIBERobn Fisiopatología de la Obesidad y Nutrición08907 Barcelona,ES
| | - José Manuel Fernández-Real
- Section of Diabetes, Endocrinology and Nutrition
University Hospital of GironaBiomedical Research Institute "Dr Josep Trueta"CIBERobn Fisiopatología de la Obesidad y Nutrición17007 Girona,ES
| | - Mònica Gratacòs
- CRG-UPF, Center for Genomic Regulation
CIBER de Epidemiología y Salud Pública (CIBERESP)C/ Dr. Aiguader, 88 08003 Barcelona, Catalonia, Spain,ES
| | - Audrey Guilmatre
- Génétique médicale et fonctionnelle du cancer et des maladies neuropsychiatriques
INSERM : U614Université de RouenUFR de Medecine et de Pharmacie 22, Boulevard Gambetta 76183 Rouen cedex,FR
- Estonian Genome and Medicine
University of Tartu51010 Tartu,EE
| | - Juliane Hoyer
- Institute of Human Genetics
Friedrich-Alexander University Erlangen-Nuremberg91054 Erlangen,DE
| | - Marjo-Riitta Jarvelin
- Department of child and adolescent health
National Institute for Health and WelfareUniversity of OuluInstitute of Health Sciences and Biocenter OuluBox 310, 90101 Oulu,FI
| | - Frank R. Kooy
- Department of Medical Genetics
University Hospital Antwerp2650 Edegem,BE
| | - Ants Kurg
- Institute of Molecular and Cell Biology
University of Tartu51010 Tartu,EE
| | - Cédric Le Caignec
- Service d'ORL et de Chirurgie Cervicofaciale
INSERM : U587Hôpital d'Enfants Armand-TrousseauUniversité Pierre et Marie Curie - Paris 6Paris,FR
| | - Katrin Männik
- Institute of Molecular and Cell Biology
University of Tartu51010 Tartu,EE
| | - Orah S. Platt
- Laboratory Medicine
Children's Hospital BostonBoston, Massachusetts 02115,US
| | - Damien Sanlaville
- Service de cytogénétique constitutionnelle
Hospices Civils de LyonCHU de LyonCentre Neuroscience et Recherche69000 Lyon,FR
| | - Mieke M. Van Haelst
- Department of Genomics of Common Disease
Imperial College LondonHammersmith hospital, London W12 0NN,GB
- Department of Medical Genetics
University Medical Center Utrecht3584 EA Utrecht,NL
| | - Sergi Villatoro Gomez
- CRG-UPF, Center for Genomic Regulation
CIBER de Epidemiología y Salud Pública (CIBERESP)C/ Dr. Aiguader, 88 08003 Barcelona, Catalonia, Spain,ES
| | - Faida Walha
- Centre de génomique intégrative
Université de Lausanne1015 Lausanne,CH
| | - Bai-Lin Wu
- Laboratory Medicine
Children's Hospital BostonBoston, Massachusetts 02115,US
- Institutes of Biomedical Science
Fudan UniversityChildren's Hospital200032 Shanghai,CN
| | - Yongguo Yu
- Laboratory Medicine
Children's Hospital BostonBoston, Massachusetts 02115,US
- Shanghai Children's Medical Center
Shanghai Children's Medical Center200127 Shanghai,CN
| | - Azzedine Aboura
- Département de génétique
Assistance publique - Hôpitaux de Paris (AP-HP)Hôpital Robert DebréUniversité Paris VII - Paris Diderot48, boulevard Sérurier 75935 Paris cedex 19,FR
| | | | - Yves Alembik
- Service de cytogénétique
CHU StrasbourgHôpital de Hautepierre1 Av Moliere 67098 Strasbourg Cedex,FR
| | | | - Benoît Arveiler
- MRGM, Maladies Rares - Génétique et Métabolisme
Hôpital PellegrinService de Génétique Médicale du CHU de BordeauxUniversité Victor Segalen - Bordeaux II : EA4576146 rue Léo-Saignat - 33076 Bordeaux Cedex,FR
- Service de génétique médicale
CHU BordeauxGroupe hospitalier PellegrinUniversité de BordeauxBordeaux,FR
| | - Magalie Barth
- Service de génétique [Angers]
CHU AngersUniversité d'Angersrue Larrey, 49100 Angers,FR
| | - Nathalie Bednarek
- URCA, Université de Reims Champagne-Ardenne
Ministère de l'Enseignement Supérieur et de la Recherche Scientifique9 boulevard Paix - 51097 Reims cedex,FR
| | - Frédérique Béna
- Génétique médicale
Hôpitaux Universitaires de Genève1205 Geneva,CH
| | - Sven Bergmann
- Department of Medical Genetics
University of LausanneCH
- SIB, Swiss Institute of Bioinformatics
Swiss Institute of BioinformaticsQuartier Sorge - Batiment Genopode 1015 Lausanne Switzerland,CH
- Department of Molecular Genetics
Weizmann Institute of ScienceRehovot,IL
| | - Mylène Beri
- Laboratoire de Génétique
CHU NancyVandoeuvre les Nancy,FR
| | - Laura Bernardini
- Mendel Laboratory
IRCCS Casa Sollievo della Sofferenza Hospital71013 San Giovanni Rotondo,IT
| | - Bettina Blaumeiser
- Department of Medical Genetics
University Hospital Antwerp2650 Edegem,BE
| | - Dominique Bonneau
- Service de génétique [Angers]
CHU AngersUniversité d'Angersrue Larrey, 49100 Angers,FR
| | - Armand Bottani
- Génétique médicale
Hôpitaux Universitaires de Genève1205 Geneva,CH
| | - Odile Boute
- Service de Génétique clinique
Hôpital Jeanne de FlandreCHRU Lille2 avenue Oscar Lambret, 59000 Lille,FR
| | - Han G. Brunner
- Department of human genetics
Radboud University Nijmegen Medical CentreNijmegen Centre for Molecular Life SciencesInstitute for Genetic and Metabolic Disorders6500 HB Nijmegen,NL
| | - Dorothée Cailley
- Service de génétique médicale
CHU BordeauxGroupe hospitalier PellegrinUniversité de BordeauxBordeaux,FR
| | | | - Jean Chiesa
- Laboratoire de Cytogénétique
CHU Nîmes30029 Nimes,FR
| | - Jacqueline Chrast
- Centre de génomique intégrative
Université de Lausanne1015 Lausanne,CH
| | - Lachlan Coin
- Department of Genomics of Common Disease
Imperial College LondonHammersmith hospital, London W12 0NN,GB
| | - Charles Coutton
- Département de génétique et procréation
CHU GrenobleUniversité Joseph Fourier - Grenoble Ifaculté de médecine-pharmacieDomaine de la Merci, 38706 Grenoble,FR
- AGIM, AGeing and IMagery, CNRS FRE3405
Université Joseph Fourier - Grenoble IEcole Pratique des Hautes EtudesCNRS : UMR5525Faculté de médecine de Grenoble, 38700 La Tronche,FR
- Laboratoire de biochimie et génétique moléculaire
CHU Grenoble38043 Grenoble,FR
| | - Jean-Marie Cuisset
- Service de Neuropédiatrie
CHRU LilleHôpital Roger Salengro59037 Lille,FR
| | | | - Albert David
- Service d'ORL et de Chirurgie Cervicofaciale
INSERM : U587Hôpital d'Enfants Armand-TrousseauUniversité Pierre et Marie Curie - Paris 6Paris,FR
| | | | - Bruno Delobel
- Centre de Génétique Chromosomique
GHICLHôpital Saint Vincent de PaulBoulevard de Belfort B.P. 387 59020 LILLE CEDEX,FR
| | - Marie-Ange Delrue
- MRGM, Maladies Rares - Génétique et Métabolisme
Hôpital PellegrinService de Génétique Médicale du CHU de BordeauxUniversité Victor Segalen - Bordeaux II : EA4576146 rue Léo-Saignat - 33076 Bordeaux Cedex,FR
- Service de génétique médicale
CHU BordeauxGroupe hospitalier PellegrinUniversité de BordeauxBordeaux,FR
| | - Bénédicte Demeer
- Service de génétique médicale
CHU AMIENSPlace Victor Pauchet, 80054 Amiens Cedex 1,FR
| | - Dominique Descamps
- Centre hospitalier de Béthune
Centre hospitalier de Béthune62408 Bethune,FR
| | - Gérard Didelot
- Centre de génomique intégrative
Université de Lausanne1015 Lausanne,CH
| | | | - Vittoria Disciglio
- Department of Biotechnology
Università degli studi di SienaMedical Genetics53100 Siena,IT
| | - Martine Doco-Fenzy
- Service de Génétique
CHU ReimsHôpital Maison BlancheIFR 5351092 Reims,FR
| | - Séverine Drunat
- Département de génétique
Assistance publique - Hôpitaux de Paris (AP-HP)Hôpital Robert DebréUniversité Paris VII - Paris Diderot48, boulevard Sérurier 75935 Paris cedex 19,FR
| | - Bénédicte Duban-Bedu
- Centre de Génétique Chromosomique
GHICLHôpital Saint Vincent de PaulBoulevard de Belfort B.P. 387 59020 LILLE CEDEX,FR
| | - Christèle Dubourg
- IGDR, Institut de Génétique et Développement de Rennes
CNRS : UMR6061Université de Rennes 1IFR140Faculté de Médecine - CS 34317 2 Av du Professeur Léon Bernard 35043 RENNES CEDEX,FR
| | | | - Paul Elliott
- Department of Epidemiology and Public Health
Imperial College LondonSt Mary's Campus, Norfolk Place, London W2 1PG,GB
| | - Brigitte H. W. Faas
- Department of human genetics
Radboud University Nijmegen Medical CentreNijmegen Centre for Molecular Life SciencesInstitute for Genetic and Metabolic Disorders6500 HB Nijmegen,NL
- Department of Human Genetics, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen
Department of Human Genetics, Radboud University Medical Centre, PO Box 9101, 6500 HB NijmegenNL
| | - Laurence Faivre
- Department of Experimental Cardiology
Heart Failure Research Center (HFRC)Academic Medical Center (AMC)Meibergdreef 9, PO Box 22660, 1100 DD Amsterdam,NL
| | - Anne Faudet
- Département de Génétique Cytogénétique et Embryologie
Assistance publique - Hôpitaux de Paris (AP-HP)Hôpital Pitié-SalpêtrièreUniversité Paris VI - Pierre et Marie Curie47-83, boulevard de l'Hôpital 75651 PARIS Cedex 13,FR
| | | | | | - Richard Fisher
- Institute of human genetics
International Centre for LifeNewcastle Upon Tyne NE1 4EP,GB
| | - Elisabeth Flori
- Service de cytogénétique
CHU StrasbourgHôpital de Hautepierre1 Av Moliere 67098 Strasbourg Cedex,FR
| | - Lukas Forer
- Division of genetic epidemiology
Innsbruck Medical UniversityDepartment of Medical GeneticsMolecular and Clinical Pharmacology6020 Innsbruck,AT
| | - Dominique Gaillard
- Service de Génétique
CHU ReimsHôpital Maison BlancheIFR 5351092 Reims,FR
| | - Marion Gerard
- Département de génétique
Assistance publique - Hôpitaux de Paris (AP-HP)Hôpital Robert DebréUniversité Paris VII - Paris Diderot48, boulevard Sérurier 75935 Paris cedex 19,FR
| | - Christian Gieger
- Institute of Experimental Medicine
Academy of Sciences of the Czech RepublicVídeÅ�ská 1083 142 20 Prague,CZ
| | - Stefania Gimelli
- Génétique médicale
Hôpitaux Universitaires de Genève1205 Geneva,CH
- Department of Obstetrics and Gynecology
Institute of Clinical MedicineUniversity of Oulu90570 Oulu,FI
| | - Giorgio Gimelli
- Laboratorio di citogenetica
G. Gaslini Institute16147 Genova,IT
| | - Hans J. Grabe
- Department of Psychiatry and Psychotherapy
Ernst-Moritz-Arndt University Greifswald17475 Greifswald and D-18437 Stralsund,DE
| | - Agnès Guichet
- Service de génétique [Angers]
CHU AngersUniversité d'Angersrue Larrey, 49100 Angers,FR
| | - Olivier Guillin
- Génétique médicale et fonctionnelle du cancer et des maladies neuropsychiatriques
INSERM : U614Université de RouenUFR de Medecine et de Pharmacie 22, Boulevard Gambetta 76183 Rouen cedex,FR
| | - Anna-Liisa Hartikainen
- Department of Obstetrics and Gynecology
Institute of Clinical MedicineUniversity of Oulu90570 Oulu,FI
| | - Délphine Heron
- Département de Génétique Cytogénétique et Embryologie
Assistance publique - Hôpitaux de Paris (AP-HP)Hôpital Pitié-SalpêtrièreUniversité Paris VI - Pierre et Marie Curie47-83, boulevard de l'Hôpital 75651 PARIS Cedex 13,FR
| | | | - Muriel Holder
- Service de Génétique clinique
Hôpital Jeanne de FlandreCHRU Lille2 avenue Oscar Lambret, 59000 Lille,FR
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics
Ernst-Moritz-Arndt University GreifswaldD-17487 Greifswald,DE
| | - Bertrand Isidor
- Service d'ORL et de Chirurgie Cervicofaciale
INSERM : U587Hôpital d'Enfants Armand-TrousseauUniversité Pierre et Marie Curie - Paris 6Paris,FR
| | - Sylvie Jaillard
- IGDR, Institut de Génétique et Développement de Rennes
CNRS : UMR6061Université de Rennes 1IFR140Faculté de Médecine - CS 34317 2 Av du Professeur Léon Bernard 35043 RENNES CEDEX,FR
| | - Zdenek Jaros
- Abteilung für Kinder und Jugendheilkunde
Landesklinikum Waldviertel Zwettl3910 Zwettl,AT
| | - Susana Jiménez-Murcia
- IDIBELL, Department of Psychiatry
University Hospital of BellvitgeCIBERobn Fisiopatología de la Obesidad y Nutrición08907 Barcelona,ES
| | | | | | - Satu Kaksonen
- The Habilitation Unit of Folkhalsan
The Habilitation Unit of FolkhalsanFolkhalsan, SF 00250 Helsinki,FI
| | - Boris Keren
- Département de Génétique Cytogénétique et Embryologie
Assistance publique - Hôpitaux de Paris (AP-HP)Hôpital Pitié-SalpêtrièreUniversité Paris VI - Pierre et Marie Curie47-83, boulevard de l'Hôpital 75651 PARIS Cedex 13,FR
| | - Anita Kloss-Brandstätter
- Division of genetic epidemiology
Innsbruck Medical UniversityDepartment of Medical GeneticsMolecular and Clinical Pharmacology6020 Innsbruck,AT
| | - Nine V. A. M. Knoers
- Department of Medical Genetics
University Medical Center Utrecht3584 EA Utrecht,NL
| | - David A. Koolen
- Department of human genetics
Radboud University Nijmegen Medical CentreNijmegen Centre for Molecular Life SciencesInstitute for Genetic and Metabolic Disorders6500 HB Nijmegen,NL
| | | | - Florian Kronenberg
- Division of genetic epidemiology
Innsbruck Medical UniversityDepartment of Medical GeneticsMolecular and Clinical Pharmacology6020 Innsbruck,AT
| | - Audrey Labalme
- Service de cytogénétique constitutionnelle
Hospices Civils de LyonCHU de LyonCentre Neuroscience et Recherche69000 Lyon,FR
| | - Emilie Landais
- Service de Génétique
CHU ReimsHôpital Maison BlancheIFR 5351092 Reims,FR
| | - Elisabetta Lapi
- Medical Genetics Unit
Children's Hospital Anna Meyer50139 Firenze,IT
| | - Valérie Layet
- Unité de Cytogénétique et Génétique Médicale
Hôpital Gustave FlaubertGroupe Hospitalier du Havre76600 Le Havre,FR
| | - Solenn Legallic
- Génétique médicale et fonctionnelle du cancer et des maladies neuropsychiatriques
INSERM : U614Université de RouenUFR de Medecine et de Pharmacie 22, Boulevard Gambetta 76183 Rouen cedex,FR
| | - Bruno Leheup
- Service de médecine infantile III et génétique clinique
CHU NancyUniversité Henri Poincaré - Nancy IPRES de l'université de Lorraine54511 Vandoeuvre les Nancy,FR
| | - Barbara Leube
- Institute of Human Genetics and Anthropology
Heinrich-Heine University Hospital DuesseldorfD-40001 Duesseldorf,DE
| | - Suzanne Lewis
- Department of Medical Genetics
University of British ColumbiaChild and Family Research InstituteVancouver V6H 3N1,CA
| | - Josette Lucas
- IGDR, Institut de Génétique et Développement de Rennes
CNRS : UMR6061Université de Rennes 1IFR140Faculté de Médecine - CS 34317 2 Av du Professeur Léon Bernard 35043 RENNES CEDEX,FR
| | - Kay D. Macdermot
- North West Thames Regional Genetics Service
Northwick Park & St Marks HospitalHarrow HA1 3UJ,GB
| | - Pall Magnusson
- Child and Adolescent Psychiatry
Landspitali University HospitalIS-105 Reykjavík,IS
| | - Christian R. Marshall
- The Centre for Applied Genomics and Program in Genetics and Genomic Biology
The Hospital for Sick ChildrenToronto, Ontario, M5G 1L7,CA
| | | | - Mark I. Mccarthy
- OCDEM, Oxford Centre for Diabetes, Endocrinology and Metabolism
University of OxfordChurchill Hospital Oxford OX3 7LJ,GB
- Wellcome Trust Centre for Human Genetics
University of OxfordOxford,GB
| | - Thomas Meitinger
- Institute of Human Genetics
HelmholtzZentrum MünchenTechnische Universität München (TUM)German Research Center for Environmental Health85764 Neuherberg,DE
| | | | - Giuseppe Merla
- Medical Genetics Unit
IRCCS Casa Sollievo della Sofferenza Hospital71013 San Giovanni Rotondo,IT
| | - Alexandre Moerman
- Service de Génétique clinique
Hôpital Jeanne de FlandreCHRU Lille2 avenue Oscar Lambret, 59000 Lille,FR
| | - Vincent Mooser
- Genetics, GlaxoSmithKline R&D
GlaxoSmithKline720 Swedeland Road, King of Prussia, Pennsylvania 19406,US
| | - Fanny Morice-Picard
- MRGM, Maladies Rares - Génétique et Métabolisme
Hôpital PellegrinService de Génétique Médicale du CHU de BordeauxUniversité Victor Segalen - Bordeaux II : EA4576146 rue Léo-Saignat - 33076 Bordeaux Cedex,FR
- Service de génétique médicale
CHU BordeauxGroupe hospitalier PellegrinUniversité de BordeauxBordeaux,FR
| | - Mafalda Mucciolo
- Department of Biotechnology
Università degli studi di SienaMedical Genetics53100 Siena,IT
| | - Matthias Nauck
- Institute of Clinical Chemistry and Laboratory Medicine
Ernst-Moritz-Arndt University GreifswaldD-17475 Greifswald,DE
| | - Ndeye Coumba Ndiaye
- Génétique cardiovasculaire
Université Henri Poincaré - Nancy I : EA437354000 Nancy,FR
| | - Ann Nordgren
- Department of Molecular Medicine and Surgery
Karolinska InstitutetSE
| | - Laurent Pasquier
- IGDR, Institut de Génétique et Développement de Rennes
CNRS : UMR6061Université de Rennes 1IFR140Faculté de Médecine - CS 34317 2 Av du Professeur Léon Bernard 35043 RENNES CEDEX,FR
| | - Florence Petit
- Service de Génétique clinique
Hôpital Jeanne de FlandreCHRU Lille2 avenue Oscar Lambret, 59000 Lille,FR
| | - Rolph Pfundt
- Department of human genetics
Radboud University Nijmegen Medical CentreNijmegen Centre for Molecular Life SciencesInstitute for Genetic and Metabolic Disorders6500 HB Nijmegen,NL
| | - Ghislaine Plessis
- Service de génétique
CHU CaenHôpital ClémenceauAvenue Georges Clémenceau, Caen,FR
| | - Evica Rajcan-Separovic
- Department of Pathology
University of British ColumbiaChild and Family Research InstituteVancouver, British Columbia V5Z 4H4,CA
| | | | - Anita Rauch
- Institute of Medical Genetics
University of Zurich8603 Schwerzenbach,CH
| | - Roberto Ravazzolo
- Department of pediatrics and CEBR
University of GenovaG. Gaslini Institute16126 Genova,IT
| | - Andre Reis
- Institute of Human Genetics
Friedrich-Alexander University Erlangen-Nuremberg91054 Erlangen,DE
| | - Alessandra Renieri
- Department of Biotechnology
Università degli studi di SienaMedical Genetics53100 Siena,IT
| | - Cristobal Richart
- Department of Internal Medicine
University Hospital Juan XXIIIUniversitat Rovira y VirgiliCiber Fisiopatologia Obesidad y Nutricion (CIBEROBN)Instituto Salud Carlos III43005 Tarragona,ES
| | - Janina S. Ried
- Institute of Experimental Medicine
Academy of Sciences of the Czech RepublicVídeÅ�ská 1083 142 20 Prague,CZ
| | - Claudine Rieubland
- Division of Human Genetics
University of BernDepartment of Paediatrics, Inselspital3010 Bern,CH
| | - Wendy Roberts
- Autism Research Unit
The Hospital for Sick Children and Bloorview Kids RehabilitationUniversity of TorontoToronto, Ontario, M5G 1Z8,CA
| | | | - Caroline Rooryck
- MRGM, Maladies Rares - Génétique et Métabolisme
Hôpital PellegrinService de Génétique Médicale du CHU de BordeauxUniversité Victor Segalen - Bordeaux II : EA4576146 rue Léo-Saignat - 33076 Bordeaux Cedex,FR
- Service de génétique médicale
CHU BordeauxGroupe hospitalier PellegrinUniversité de BordeauxBordeaux,FR
| | - Massimiliano Rossi
- Service de cytogénétique constitutionnelle
Hospices Civils de LyonCHU de LyonCentre Neuroscience et Recherche69000 Lyon,FR
| | | | - Véronique Satre
- Département de génétique et procréation
CHU GrenobleUniversité Joseph Fourier - Grenoble Ifaculté de médecine-pharmacieDomaine de la Merci, 38706 Grenoble,FR
- AGIM, AGeing and IMagery, CNRS FRE3405
Université Joseph Fourier - Grenoble IEcole Pratique des Hautes EtudesCNRS : UMR5525Faculté de médecine de Grenoble, 38700 La Tronche,FR
| | - Claudia Schurmann
- Interfaculty Institute for Genetics and Functional Genomics
Ernst-Moritz-Arndt University GreifswaldD-17487 Greifswald,DE
| | - Engilbert Sigurdsson
- University of Iceland
University of IcelandDepartment of Electrical and Computer Engineering, University of Iceland, Hjardarhaga 2-6, 107 Reykjavik, Iceland;,IS
| | - Dimitri J. Stavropoulos
- Department of Pediatric Laboratory Medicine
Hospital for Sick ChildrenToronto, Ontario M5G 1X8,CA
| | | | - Carola Tengström
- Genetic Services
Rinnekoti Research FoundationKumputie 1, SF-02980 Espoo,FI
| | | | - Francisco J. Tinahones
- Department of Endocrinology and Nutrition
Clinic Hospital of Virgen de la VictoriaCiber Fisiopatologia y Nutricion (CIBEROBN)Instituto Salud Carlos III29010 Malaga,ES
| | - Renaud Touraine
- Service de génétique
CHU Saint-EtienneHôpital nord42055 St Etienne,FR
| | - Louis Vallée
- Service de Neuropédiatrie
CHRU LilleHôpital Roger Salengro59037 Lille,FR
| | - Ellen Van Binsbergen
- Department of Medical Genetics
University Medical Center Utrecht3584 EA Utrecht,NL
| | | | - Catherine Vincent-Delorme
- Centre de Maladies Rares
Anomalies du Développement Nord de FranceCH Arras - CHRU Lille59000 Arras,FR
| | - Sophie Visvikis-Siest
- Génétique cardiovasculaire
Université Henri Poincaré - Nancy I : EA437354000 Nancy,FR
| | - Peter Vollenweider
- Department of Internal Medicine
Centre Hospitalier Universitaire Vaudois1011 Lausanne,CH
| | - Henry Völzke
- Institute for Community Medicine
Ernst-Moritz-Arndt University GreifswaldD-17475 Greifswald,DE
| | - Anneke T. Vulto-Van Silfhout
- Department of human genetics
Radboud University Nijmegen Medical CentreNijmegen Centre for Molecular Life SciencesInstitute for Genetic and Metabolic Disorders6500 HB Nijmegen,NL
| | - Gérard Waeber
- Department of Internal Medicine
Centre Hospitalier Universitaire Vaudois1011 Lausanne,CH
| | - Carina Wallgren-Pettersson
- Department of Medical Genetics
University of HelsinskiFolkhälsan Insitute of GeneticsHaartman Institute00251 Helsinki,FI
| | | | - Simon Zwolinksi
- Institute of human genetics
International Centre for LifeNewcastle Upon Tyne NE1 4EP,GB
| | - Joris Andrieux
- Laboratoire de Génétique Médicale
Hôpital Jeanne de FlandreCHRU Lille59037 Lille Cedex,FR
| | - Xavier Estivill
- CRG-UPF, Center for Genomic Regulation
CIBER de Epidemiología y Salud Pública (CIBERESP)C/ Dr. Aiguader, 88 08003 Barcelona, Catalonia, Spain,ES
| | - James F. Gusella
- Center for Human Genetic Research
Massachusetts General HospitalBoston, Massachusetts 02114,US
| | | | - Andres Metspalu
- Estonian Genome and Medicine
University of Tartu51010 Tartu,EE
- Institute of Molecular and Cell Biology
University of Tartu51010 Tartu,EE
| | - Stephen W. Scherer
- The Centre for Applied Genomics
The Hospital for Sick ChildrenMcLaughlin CentreDepartment of Molecular GeneticsUniversity of TorontoToronto, Ontario, Canada M5G 1L7,CA
| | | | - Alexandra I. F. Blakemore
- Department of Genomics of Common Disease
Imperial College LondonHammersmith hospital, London W12 0NN,GB
| | - Jacques S. Beckmann
- Service de génétique médicale
CHU Vaudois1011 Lausanne,CH
- Department of Medical Genetics
University of LausanneCH
| | - Philippe Froguel
- Department of Genomics of Common Disease
Imperial College LondonHammersmith hospital, London W12 0NN,GB
- IBLI, Institut de biologie de Lille - IBL
Institut Pasteur de LilleCNRS : UMR8090Université Lille I - Sciences et technologiesUniversité Lille II - Droit et santéInstitut de Biologie de Lille 1 Rue du Professeur Calmette - 447 59021 LILLE CEDEX,FR
| |
Collapse
|
32
|
Debette S, Visvikis-Siest S, Chen MH, Ndiaye NC, Song C, Destefano A, Safa R, Azimi Nezhad M, Sawyer D, Marteau JB, Xanthakis V, Siest G, Sullivan L, Pfister M, Smith H, Choi SH, Lamont J, Lind L, Yang Q, Fitzgerald P, Ingelsson E, Vasan RS, Seshadri S. Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. Circ Res 2011; 109:554-63. [PMID: 21757650 DOI: 10.1161/circresaha.111.243790] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
RATIONALE Vascular endothelial growth factor (VEGF) affects angiogenesis, atherosclerosis, and cancer. Although the heritability of circulating VEGF levels is high, little is known about its genetic underpinnings. OBJECTIVE Our aim was to identify genetic variants associated with circulating VEGF levels, using an unbiased genome-wide approach, and to explore their functional significance with gene expression and pathway analysis. METHODS AND RESULTS We undertook a genome-wide association study of serum VEGF levels in 3527 participants of the Framingham Heart Study, with preplanned replication in 1727 participants from 2 independent samples, the STANISLAS Family Study and the Prospective Investigation of the Vasculature in Uppsala Seniors study. One hundred forty single nucleotide polymorphism (SNPs) reached genome-wide significance (P<5×10(-8)). We found evidence of replication for the most significant associations in both replication datasets. In a conditional genome-wide association study, 4 SNPs mapping to 3 chromosomal regions were independently associated with circulating VEGF levels: rs6921438 and rs4416670 (6p21.1, P=6.11×10(-506) and P=1.47×10(-12)), rs6993770 (8q23.1, P=2.50×10(-16)), and rs10738760 (9p24.2, P=1.96×10(-34)). A genetic score including these 4 SNPs explained 48% of the heritability of serum VEGF levels. Six of the SNPs that reached genome-wide significance in the genome-wide association study were significantly associated with VEGF messenger RNA levels in peripheral blood mononuclear cells. Ingenuity pathway analyses showed found plausible biological links between VEGF and 2 novel genes in these loci (ZFPM2 and VLDLR). CONCLUSIONS Genetic variants explaining up to half the heritability of serum VEGF levels were identified. These new insights provide important clues to the pathways regulating circulating VEGF levels.
Collapse
Affiliation(s)
- Stephanie Debette
- Department of Neurology, Boston University School of Medicine, B602, 72 East Concord St, Boston, MA 02118, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Nzietchueng R, El Shamieh S, Benachour H, Labat C, Herbeth B, Ndiaye NC, Masson C, Visvikis-Siest S, Benetos A. Klotho KL-VS genotype is involved in blood pressure regulation. Clin Chim Acta 2011; 412:1773-7. [PMID: 21663735 DOI: 10.1016/j.cca.2011.05.032] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2011] [Revised: 05/24/2011] [Accepted: 05/26/2011] [Indexed: 12/19/2022]
Abstract
BACKGROUND AND AIMS Genome-wide linkage analysis studies reported the importance of the long arm of chromosome 13 in systolic blood pressure regulation. Therefore, isolating a genetic variant related to this chromosomal region could be challenging. Klotho KL-VS allele is located on this chromosomal region and its relationships with cardio-vascular risk factors need extensive investigations. The aim of the present study is to examine whether the klotho KL-VS genotype is associated with cardio-vascular risk factors, more particularly hypertension, in two independent cohorts. A secondary objective was to investigate relationships with antihypertensive treatment, arterial stiffness and carotid artery parameters. METHODS AND RESULTS A total of 1023 French individuals were genotyped for klotho KL-VS. Participants were part of the French ERA and STANISLAS cohorts. In both cohorts, klotho KL-VS/KL-VS genotype was significantly associated with lower systolic blood pressure and pulse pressure when compared to homozygous and heterozygous more frequent (WT) allele carriers (p=0.003 and p<0.001 respectively). Antihypertensive treatment stratification confirmed the previous significant associations, while a significant interaction between klotho KL-VS genotype and antihypertensive treatment was also interestingly found (0.019 for p interaction). CONCLUSION Klotho KL-VS/KL-VS genotype may be associated with decreased cardio-vascular risk and may interact with antihypertensive treatment in order to reduce blood pressure. This finding could lead to identify subgroups of hypertensive adults who might benefit antihypertensive drug therapies.
Collapse
Affiliation(s)
- Rosine Nzietchueng
- Department of Internal Medicine and Geriatrics, INSERM U, University of Nancy, France
| | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Buxton JL, Walters RG, Visvikis-Siest S, Meyre D, Froguel P, Blakemore AIF. Childhood obesity is associated with shorter leukocyte telomere length. J Clin Endocrinol Metab 2011; 96:1500-5. [PMID: 21349907 PMCID: PMC3137462 DOI: 10.1210/jc.2010-2924] [Citation(s) in RCA: 117] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CONTEXT Obesity in adults is associated with shorter mean leukocyte telomere length (LTL), a marker of biological age that is also associated with age-related conditions including cardiovascular disease and type 2 diabetes. However, studies of childhood obesity and LTL have proved inconclusive. OBJECTIVE The objective of the study was to clarify the relationship between telomere length and childhood obesity by measuring the average LTL in a large case-control cohort. PARTICIPANTS AND METHODS LTL was measured in 793 French children aged 2-17 yr (471 with early onset obesity and 322 nonobese controls) using multiplex quantitative real-time PCR. The average LTL in the two groups was compared, and the relationships between telomere length and selected anthropometric and biochemical measurements were examined. RESULTS Obese children had a mean LTL that was 23.9% shorter than that of nonobese children (P < 0.0001). Telomere length was inversely associated with age (R = -0.17, P = 0.002 in controls; R = -0.15, P = 0.001 in cases), log weight (R= -0.13, P = 0.017 in controls; R = -0.16, P = 0.0004 in cases), and height (R = -0.15, P = 0.008 in controls; R = -0.17, P = 0.0002 in cases). The mean LTL of girls and boys was not significantly different in either the cases or controls or in the group overall. CONCLUSION Obese girls and boys have significantly shorter leukocyte telomeres than their nonobese counterparts, a finding that highlights a potentially deleterious impact of early onset obesity on future health.
Collapse
Affiliation(s)
- Jessica L Buxton
- Department of Genomics of Common Disease, School of Public Health, Imperial College London, Burlington-Danes Building, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom.
| | | | | | | | | | | |
Collapse
|
35
|
El Shamieh S, Herbeth B, Azimi-Nezhad M, Benachour H, Masson C, Visvikis-Siest S. Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels. Clin Chim Acta 2010; 413:34-8. [PMID: 21144844 DOI: 10.1016/j.cca.2010.11.038] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2010] [Revised: 11/29/2010] [Accepted: 11/30/2010] [Indexed: 01/11/2023]
Abstract
BACKGROUND Human formyl peptide receptor 1 (FPR1) mediates inflammatory responses, recognized as important participants in the physiopathology of hypertension. Similarly, FPR1 C32T SNP is associated with inflammation and BP related pathways. Therefore, the relationship between FPR1 C32T SNP, BP and hypertension needs to be investigated. METHOD 1012 French middle-aged adults including 491 healthy individuals (5 years follow-up, T(+0) and T(+5)) and 521 hypertensive individuals were PCR-RFLP genotyped for FPR1 C32T SNP (rs5030878). RESULTS At entrance, there was no significant association between FPR1 C32T SNP and blood pressure (BP) in healthy individuals. However, 5 years later, significant associations were found for DBP, SBP (p<0.001 and p=0.009 respectively) and for their 5 years changes (Δ) (p=0.025 and p=0.027 for DBP and SBP respectively). Significant interactions between FPR1 C32T SNP and age on DBP, SBP, ΔDBP and ΔSBP were found (p=0.014, 0.008, 0.015 and 0.015 respectively). Consequently, stronger increase in BP was reported among healthy individuals aged less than 45 years. When normotensive individuals were compared to hypertensives ones, similar FPR1 C32T genotypes and allele frequency distributions were found. CONCLUSION FPR1 C32T SNP interacts with age, is associated with higher and a 5 years increase of BP levels in healthy individuals aged less than 45 years.
Collapse
Affiliation(s)
- Said El Shamieh
- Unité de recherche Génétique Cardiovasculaire, EA-4373, Université Henri Poincaré-Nancy 1, Faculté de Pharmacie, Nancy, France
| | | | | | | | | | | |
Collapse
|
36
|
Antoni G, Morange PE, Luo Y, Saut N, Burgos G, Heath S, Germain M, Biron-Andreani C, Schved JF, Pernod G, Galan P, Zelenika D, Alessi MC, Drouet L, Visvikis-Siest S, Wells PS, Lathrop M, Emmerich J, Tregouet DA, Gagnon F. A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism. J Thromb Haemost 2010; 8:2671-9. [PMID: 20946148 DOI: 10.1111/j.1538-7836.2010.04092.x] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
BACKGROUND Factor VIII (FVIII) and von Willebrand factor (VWF) are two known quantitative risk factors for venous thromboembolism (VTE). OBJECTIVES To identify new loci that could contribute to VTE susceptibility and to modulating FVIII and/or VWF levels. PATIENTS/METHODS A pedigree linkage analysis was first performed in five extended French-Canadian families, including 253 individuals, to identify genomic regions linked to FVIII or VWF levels. Identified regions were further explored using 'in silico' genome-wide association studies (GWAS) data on VTE (419 patients and 1228 controls), and two independent case-control studies (MARTHA and FARIVE) for VTE, gathering 1166 early-onset patients and 1408 healthy individuals. Single nucleotide polymorphisms (SNPs) associated with VTE risk were further investigated in relation to plasma levels of FVIII and VWF in a cohort of 108 healthy nuclear families. RESULTS Four main linkage regions were identified, among which the well-characterized ABO locus, the recently identified STAB 2 gene, and a third one, on chromosome 6q13-14, harbouring four non-redundant SNPs, associated with VTE at P < 10(-4) in the GWAS dataset. The association of one of these SNPs, rs9363864, with VTE was further replicated in the MARTHA and FARIVE studies. The rs9363864-AA genotype was associated with a lower risk for VTE (OR = 0.58 [0.42-0.80], P = 0.0005) but mainly in non-carriers of the FV Leiden mutation. This genotype was further found to be associated with the lowest levels of FVIII (P = 0.006) and VWF (P = 0.001). CONCLUSIONS The BAI3 locus where the rs9363864 maps is a new candidate for VTE risk.
Collapse
Affiliation(s)
- G Antoni
- INSERM UMRS 937, Université Pierre et Marie Curie, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: genetic heritability and common environmental influences. Clin Chim Acta 2010; 411:833-9. [PMID: 20219453 DOI: 10.1016/j.cca.2010.02.070] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2010] [Revised: 02/23/2010] [Accepted: 02/23/2010] [Indexed: 01/21/2023]
Abstract
BACKGROUND We estimated genetic heritability and common environmental influences for various traits related to metabolic syndrome in young families from France. METHODS At entrance and after 5 years, nineteen traits related to metabolic syndrome were measured in a sample of families drawn from the STANISLAS study. In addition, 5 aggregates of these traits were identified using factor analysis. RESULTS At entrance, genetic heritability was high (20 to 44%) for plasma lipids and lipoproteins, uric acid, fasting glucose, and the related clusters "risk lipids" and "protective lipids". Intermediate or low genetic heritability (less than 20%) was shown for triglycerides, adiposity indices, blood pressure, hepatic enzyme activity, inflammatory makers and the related clusters: "liver enzymes", "adiposity/blood pressure" and "inflammation". Moreover, common environmental influences were significant for all the parameters. With regard to 5-year changes, polygenic variance was low and not statistically significant for any of the individual variables or clusters whereas shared environment influence was significant. CONCLUSIONS In these young families, genetic heritability of metabolic syndrome-related traits was generally lower than previously reported while the common environmental influences were greater. In addition, only shared environment contributed to short-term changes of these traits.
Collapse
|
38
|
Meyre D, Proulx K, Kawagoe-Takaki H, Vatin V, Gutiérrez-Aguilar R, Lyon D, Ma M, Choquet H, Horber F, Van Hul W, Van Gaal L, Balkau B, Visvikis-Siest S, Pattou F, Farooqi IS, Saudek V, O'Rahilly S, Froguel P, Sedgwick B, Yeo GS. Prevalence of loss-of-function FTO mutations in lean and obese individuals. Diabetes 2010; 59:311-8. [PMID: 19833892 PMCID: PMC2797938 DOI: 10.2337/db09-0703] [Citation(s) in RCA: 87] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE Single nucleotide polymorphisms (SNPs) in intron 1 of fat mass- and obesity-associated gene (FTO) are strongly associated with human adiposity, whereas Fto(-/-) mice are lean and Fto(+/-) mice are resistant to diet-induced obesity. We aimed to determine whether FTO mutations are disproportionately represented in lean or obese humans and to use these mutations to understand structure-function relationships within FTO. RESEARCH DESIGN AND METHODS We sequenced all coding exons of FTO in 1,433 severely obese and 1,433 lean individuals. We studied the enzymatic activity of selected nonsynonymous variants. RESULTS We identified 33 heterozygous nonsynonymous variants in lean (2.3%) and 35 in obese (2.4%) individuals, with 8 mutations unique to the obese and 11 unique to the lean. Two novel mutations replace absolutely conserved residues: R322Q in the catalytic domain and R96H in the predicted substrate recognition lid. R322Q was unable to catalyze the conversion of 2-oxoglutarate to succinate in the presence or absence of 3-methylthymidine. R96H retained some basal activity, which was not enhanced by 3-methylthymidine. However, both were found in lean and obese individuals. CONCLUSIONS Heterozygous, loss-of-function mutations in FTO exist but are found in both lean and obese subjects. Although intron 1 SNPs are unequivocally associated with obesity in multiple populations and murine studies strongly suggest that FTO has a role in energy balance, it appears that loss of one functional copy of FTO in humans is compatible with being either lean or obese. Functional analyses of FTO mutations have given novel insights into structure-function relationships in this enzyme.
Collapse
Affiliation(s)
- David Meyre
- CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France
| | - Karine Proulx
- University of Cambridge Metabolic Research Labs, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K
| | - Hiroko Kawagoe-Takaki
- Cancer Research U.K. London Research Institute, Clare Hall Laboratories, South Mimms, Hertfordshire, U.K
| | - Vincent Vatin
- CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France
| | | | - Debbie Lyon
- Cancer Research U.K. London Research Institute, Clare Hall Laboratories, South Mimms, Hertfordshire, U.K
| | - Marcella Ma
- University of Cambridge Metabolic Research Labs, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K
| | - Helene Choquet
- CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France
| | - Fritz Horber
- Klinik Lindberg, Winterthur, and University of Berne, Berne, Switzerland
| | - Wim Van Hul
- Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium
| | - Luc Van Gaal
- Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Edegem, Belgium
| | - Beverley Balkau
- INSERM U780, Villejuif, France, and University Paris-Sud, Orsay, France
| | | | - François Pattou
- INSERM U859, CHRU Lille, Lille North of France University, Lille, France
| | - I. Sadaf Farooqi
- University of Cambridge Metabolic Research Labs, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K
| | - Vladimir Saudek
- University of Cambridge Metabolic Research Labs, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K
| | - Stephen O'Rahilly
- University of Cambridge Metabolic Research Labs, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K
| | - Philippe Froguel
- CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France
- Section of Genomic Medicine, Hammersmith Hospital, Imperial College London, London, U.K
| | - Barbara Sedgwick
- Cancer Research U.K. London Research Institute, Clare Hall Laboratories, South Mimms, Hertfordshire, U.K
| | - Giles S.H. Yeo
- University of Cambridge Metabolic Research Labs, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K
- Corresponding author: Giles Yeo,
| |
Collapse
|
39
|
Sertic J, Juricic L, Ljubic H, Bozina T, Lovric J, Markeljevic J, Jelakovic B, Merkler M, Reiner Z. Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity. BMC Res Notes 2009; 2:203. [PMID: 19804633 PMCID: PMC2765961 DOI: 10.1186/1756-0500-2-203] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2009] [Accepted: 10/05/2009] [Indexed: 11/10/2022] Open
Abstract
FINDINGS BMI was increased (>25) in 22% of young healthy subjects. Increased cholesterol values (>5.0 mmol/L) were found in 23% of subjects, LDL-C (>3.0 mmol/L) in 23%, triglycerides (>1.7 mmol/L) in 11% of subjects. We found statistically significant differences in subjects' weight (p = 0.015), BMI (p = 0.023), and waist-hip ratio (WHR) (p = 0.015) in regard to their diet type; subjects with Mediterranean diet had the lowest values compared to those on continental and mixed diet. Significant associations were found for: LPL genetic polymorphic variant and abdominal obesity (p = 0.013), APO epsilon4 allele and hypercholesterolemia (p = 0.003), and ESR1-TA long allele and hypercholesterolemia (p = 0.011). BACKGROUND Human obesity is a multifactorial syndrome influenced also by genetic factors. Among gene variants found to be involved in body weight regulation and development of obesity, particular attention has been paid to polymorphisms in genes associated with obesity-related metabolic disorders. We explored the association of genetic polymorphisms of: estrogen receptor alpha (ESR1-TA repeats); interleukin-6 (IL-6 G-174C); apolipoprotein E (APO epsilon2, epsilon3, epsilon4); lipoprotein lipase Pvu II (LPL P+/-), with clinical variables: gender, age, body mass index (BMI), diet type and biological variables: triglycerides, cholesterol, HDL-C, LDL-C, CRP, homocysteine, urate, and glucose in 105 healthy young subjects (20-35 yrs) of Croatian origin. METHODS Genotyping of IL-6, LPL was performed by PCR-RFLP, of APOE by real-time PCR, and of ESR1 by PCR and capillary electrophoresis. Association analyses were performed of alleles and genotypes with biological variables. CONCLUSION ESR-1, LPL, and APO E genetic polymorphic variants could represent predictive genetic risk markers for obesity-related metabolic disorders in young healthy subjects. Mediterranean type of diet is also an important protective factor against abdominal obesity.
Collapse
Affiliation(s)
- Jadranka Sertic
- Clinical Institute of Laboratory Diagnosis, Zagreb University Hospital Centre, Zagreb, Croatia.
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Ndiaye NC, Albuisson É, Colombet I, Chatellier G, Marteau JB, Dadé S, Siest G, Visvikis-Siest S. Parental precocious influences on offspring cardiovascular risk markers: an exploratory study in the STANISLAS Cohort. Per Med 2009; 6:343-352. [PMID: 29783507 DOI: 10.2217/pme.09.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Familial history of cardiovascular disease is acknowledged as a risk indicator in offspring. The aim of this study was to assess whether the cardiovascular risk factors in parents predicted the risk of their children developing cardiovascular disease in a French population: the STANISLAS Cohort, in which Caucasian biparental families with at least two siblings were followed for 5 years. Silent risk factors (blood pressure, lipid traits, glycemia, BMI and waist circumference) of children were compared according to their parents' risk status in a subsample of 693 families. All of these traits, with the exception of glucose, were significantly higher in children who had parents at a high risk than in children with parents at a low risk at the first health examination, and these results were confirmed again 5 years later at the second health examination. Thus, silent cardio-metabolic risk factors can be screened in children according to the risk status of their parents for early prevention. The influence of parents' variants on their offspring underlined the need to initiate familial prevention strategies, with a particular follow-up of young individuals between childhood and adolescence.
Collapse
Affiliation(s)
- Ndeye Coumba Ndiaye
- Université Henri Poincaré Nancy I - Faculté de Pharmacie, Équipe 'Génétique Cardiovasculaire' - 30 rue Lionnois, F-54000, Nancy, France.
| | - Éliane Albuisson
- Université Henri Poincaré Nancy I - Faculté de Pharmacie, Équipe 'Génétique Cardiovasculaire' - 30 rue Lionnois, F-54000, Nancy, France. .,Centre Hospitalier Universitaire, Nancy, France
| | - Isabelle Colombet
- Université Paris V, Paris, France.,Hôpital Européen Georges Pompidou, Paris, France
| | - Gilles Chatellier
- Université Paris V, Paris, France.,Hôpital Européen Georges Pompidou, Paris, France
| | - Jean-Brice Marteau
- Université Henri Poincaré Nancy I - Faculté de Pharmacie, Équipe 'Génétique Cardiovasculaire' - 30 rue Lionnois, F-54000, Nancy, France.
| | - Sébastien Dadé
- Université Henri Poincaré Nancy I - Faculté de Pharmacie, Équipe 'Génétique Cardiovasculaire' - 30 rue Lionnois, F-54000, Nancy, France.
| | - Gérard Siest
- Université Henri Poincaré Nancy I - Faculté de Pharmacie, Équipe 'Génétique Cardiovasculaire' - 30 rue Lionnois, F-54000, Nancy, France.
| | - Sophie Visvikis-Siest
- Université Henri Poincaré Nancy I - Faculté de Pharmacie, Équipe 'Génétique Cardiovasculaire' - 30 rue Lionnois, F-54000, Nancy, France.
| |
Collapse
|
41
|
Siest G. Systems biology and personalized prevention. Per Med 2009; 6:265-268. [PMID: 29783511 DOI: 10.2217/pme.09.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Affiliation(s)
- Gérard Siest
- Unité de Recherche 'Génétique Cardiovasculaire', Nancy Université Henri Poincaré, France.
| |
Collapse
|
42
|
Marteau JB, Samara A, Dedoussis G, Pfister M, Visvikis-Siest S. Candidate gene microarray analysis in peripheral blood cells for studying hypertension/obesity. Per Med 2009; 6:269-291. [PMID: 29783504 DOI: 10.2217/pme.09.6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
AIMS The gene expression of 182 cardiovascular candidate genes was measured in high quality groups of individuals (n = 20) by microarrays to determine whether a subset of genes would discriminate obese and hypertensive individuals, in spite of the existence of a close link between these two cardiovascular risk factors. MATERIALS & METHODS The results were validated on the 20 subjects used for microarray analysis and on 62 additional individuals by real-time PCR. RESULTS The first analysis, where patient groups were compared with healthy subjects, revealed 15 out of 182 genes that differed in hypertensive, obese or obesity-related hypertensive individuals. These genes were ALOX5, APOA2, SELL, RGS2, CD14, FPR1, CAMP, DEFA3, DEFA4, CBS, CHRM1, ICAM1, NR1H2, SCNN1B and TGFB1. A second analysis was carried out in which patient groups were compared with each other, demonstrating FPR1 and DEFA3 as being significant genes discriminating patient groups. Furthermore, an analysis stratified by sex revealed that, with the exception of DEFA3, there are no other common genes between men and women. DISCUSSION We were able to indentify a number of interesting genes that distinguish patient and healthy subject groups as well as patient groups between them. CONCLUSION In addition, it seems that gender plays an important role, at least for some of the genes we tested. These findings may have important implications in the screening and etiology of hypertension or obesity, and could further help to focus on these specific mRNAs as antisense therapy targets.
Collapse
Affiliation(s)
- Jean-Brice Marteau
- Nancy Université Henri Poincaré, Faculté de Pharmacie, Unité de recherche Génétique Cardiovasculaire, 30 rue Lionnois, 54000 Nancy, France.
| | - Anastasia Samara
- Nancy Université Henri Poincaré, Faculté de Pharmacie, Unité de recherche Génétique Cardiovasculaire, 30 rue Lionnois, 54000 Nancy, France.
| | | | - Michèle Pfister
- Nancy Université Henri Poincaré, Faculté de Pharmacie, Unité de recherche Génétique Cardiovasculaire, 30 rue Lionnois, 54000 Nancy, France.
| | - Sophie Visvikis-Siest
- Nancy Université Henri Poincaré, Faculté de Pharmacie, Unité de recherche Génétique Cardiovasculaire, 30 rue Lionnois, 54000 Nancy, France.
| |
Collapse
|
43
|
Berrahmoune H, Lamont JV, Herbeth B, Lambert D, Masson C, McPhillips M, FitzGerald PS, Visvikis-Siest S. Association between EGF and lipid concentrations: A benefit role in the atherosclerotic process? Clin Chim Acta 2009; 402:196-8. [DOI: 10.1016/j.cca.2008.12.033] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2008] [Revised: 12/23/2008] [Accepted: 12/23/2008] [Indexed: 10/21/2022]
|
44
|
Jeannesson E, Siest G, Bastien B, Albertini L, Aslanidis C, Schmitz G, Visvikis-Siest S. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort. Clin Chim Acta 2009; 403:198-202. [PMID: 19285054 DOI: 10.1016/j.cca.2009.02.019] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2008] [Revised: 02/27/2009] [Accepted: 02/27/2009] [Indexed: 01/11/2023]
Abstract
BACKGROUND While involvement of ABCB1 is well known in drug transport, its metabolite transport role is not so well understood. Like other ABC transporters, ABCB1 might be implicated in cholesterol homeostasis and ABCB1 polymorphisms which are responsible for drug resistance might affect lipid homeostasis. Our objective was thus to investigate the implication of ABCB1 polymorphisms and haplotypes in the genetic variability of lipid constituents in healthy people. METHODS T-129C, G-1A, A61G, G1199A, C1236T, T-76A, G2677T/A and C3435T polymorphisms were genotyped in 371 supposed healthy individuals from the STANISLAS cohort. Each polymorphism was tested with plasma concentrations of total cholesterol, HDL and LDL cholesterol, triglycerides and apolipoproteins A1, B, C3 and E. RESULTS After adjustment for covariates, carriers of at least one 3435T allele had a significant higher level of apolipoprotein A1 (p = 0.005). In addition, significant correlations were observed in a sex-dependent manner. Women carrying either T-76 or 1236T allele (tendency with G-1 and 2677T/A) had lower total cholesterol (p < or = 0.01) and apolipoprotein B (T-76 exclusively, p=0.002). Haplotypes analysis was not more informative than the single polymorphisms except G2677T/A-C3435T haplotypes for apolipoprotein A1 concentration. CONCLUSION ABCB1 polymorphisms contribute to the genetic variability of plasma values of lipids and lipoproteins in healthy people.
Collapse
Affiliation(s)
- Elise Jeannesson
- Unité de recherche Génétique Cardiovasculaire, Faculté de Pharmacie de Nancy, Université Henri Poincaré, France
| | | | | | | | | | | | | |
Collapse
|
45
|
Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, Sparsø T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chèvre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jørgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S, Balkau B, Lévy-Marchal C, Pattou F, Meyre D, Blakemore AIF, Jarvelin MR, Walley AJ, Hansen T, Dina C, Pedersen O, Froguel P. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2008; 41:89-94. [PMID: 19060909 DOI: 10.1038/ng.277] [Citation(s) in RCA: 434] [Impact Index Per Article: 27.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2008] [Accepted: 10/14/2008] [Indexed: 12/11/2022]
Abstract
In genome-wide association (GWA) data from 2,151 nondiabetic French subjects, we identified rs1387153, near MTNR1B (which encodes the melatonin receptor 2 (MT2)), as a modulator of fasting plasma glucose (FPG; P = 1.3 x 10(-7)). In European populations, the rs1387153 T allele is associated with increased FPG (beta = 0.06 mmol/l, P = 7.6 x 10(-29), N = 16,094), type 2 diabetes (T2D) risk (odds ratio (OR) = 1.15, 95% CI = 1.08-1.22, P = 6.3 x 10(-5), cases N = 6,332) and risk of developing hyperglycemia or diabetes over a 9-year period (hazard ratio (HR) = 1.20, 95% CI = 1.06-1.36, P = 0.005, incident cases N = 515). RT-PCR analyses confirm the presence of MT2 transcripts in neural tissues and show MT2 expression in human pancreatic islets and beta cells. Our data suggest a possible link between circadian rhythm regulation and glucose homeostasis through the melatonin signaling pathway.
Collapse
Affiliation(s)
- Nabila Bouatia-Naji
- CNRS-UMR-8090, Institute of Biology and Lille 2 University, Pasteur Institute, Lille, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|